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The effect of zinc status on the cell signaling transduction of tumor suppressor genes, 
Growth Arrest and DNA Damage inducible gene (Gadd45), p53, and p38 Mitogen 
Activated Protein Kinase (MAPK) were examined in Normal Human Bronchial 
Epithelial (NHBE) cells. Cells were cultured for one passage in different concentrations 
of zinc: < 0.4 μM (ZD, zinc-deficient); 4 μM (ZN, zinc normal) as normal zinc level 
found in most culture medium; 16 μM (ZA, zinc adequate) represented normal human 
plasma zinc level; and 32 μM (ZS, zinc supplementation) represented the optimal plasma 
zinc attainable by oral supplementation. Cell growth inhibition, up-regulation of Gadd45, 
p53 and p38 MAPK mRNA and protein expressions, and blockage of G2/M cell cycle 
progression were observed in ZS cells. The siRNA-mediated knocking down of Gadd45 
was found to alleviate G2/M blockage partially in ZS cells, which indicated that the 
blockage is partially Gadd45 dependent. In ZS cells, the enhanced phosphorylation of 
p38 MAPK and p53 were abrogated after suppressing Gadd45 by siRNA, implicating 
that the enhanced phosphorylation of p53 and p38 MAPK were Gadd45 dependent. By 
using p53 transactivation inhibitor Pifithrin, the upregulated Gadd45 protein, the 
enhanced Gadd45 promoter activity, and the reduced level of CDK1/Cyclin B1 complex 
were all restored back to normal levels in ZS cell, implying that these ZS induced 
changes were p53 dependent.  Furthermore, the ZS induced upregulation of Gadd45 
expression, displacement of CDC25B from nucleus to cytoplasm, reduction of 
CDK1/Cyclin B1 complex level, enhancement of the activation and phosphorylation of 
p53, and delay of G2/M cell cycle progression were normalized by p38 MAPK dominant 
negative and protein inhibitor SB202190. Thus, the ZS induced changes were dependent 
on the activation of p38 MAPK. Our data support the involvement of a positive Gadd45, 
p53 and p38 MAPK feedback loop in response to stress induced by zinc supplementation.  
These findings demonstrate the importance of p38 MAPK and p53 in the regulation of 
G2/M cell cycle progression in response to the stress induced by high zinc via Gadd45 
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m
d to
a lesser ext in human populations, the present studies were designed to examine
8, p53 and Gadd45 signaling transduction cascade on G2/M cell c
 
ycle
progression in Normal Human Bronchial Epithelial (NHBE) cells. NHBE cells are 
lected because they represent target cells in human lung disease (Stoner et al., 1980), 
uring lung transformation and they 
red be 
considered as ell 
carcinogenesis (
se
they are more representative of the cell population d
are conside to be progenitor cells for human bronchial cancer. Thus, they ca
an excellent model for investigating human lung epithelial 
Lechner and LaVeck, 1985). 
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The Growth Arrest and DNA Damage-inducible gene, Gadd45, has been implic
f cell cycle checkpoint, DNA repair process and signaling transduc
f Gadd45 is dependent on the transactivation of p53, a tumor suppre
ated 
in the control o n. 




gene kno r preserving genomic integrity. Upon DNA damage Mitogen-Activated 
Protein Kinase (MAPK) p38 m
implicated in G2/M cell cycle progression Various studies demonstrated a functional 
association between stress-activated MAPK pathway and Gadd45 in response to 
environmental stresses.  
In the current project, we proposed five hypotheses. Firstly, in zinc-supplemented 
(ZS) NHBE cells, the up-regulated Gadd45 mRNA and protein expressions block G2/M 
cell cycle progression and inhibit cell gr th. Secondly, in ZS NHBE cells, the 




upregulated Gadd45 expression is mediated through the p53 dependent pathway. Thirdly, 
the upregulation of p53 is responsible for th G2/M blockage in ZS NHBE cells induced 
by the reduced CDK1 and Cyclin B1 comp x level. Fourthly, an enhanced p38 MAPK 
activity induces the displacement of CDC25B from nucleus to cytoplasm compartment as 
well as a reduction of CDK1/Cyclin B1 complex level, which are responsible for the 
G2/M blockage in ZS NHBE cells. Fifthly, S NHBE cells, the induction of Gadd45, 
p38 MAPK, and p53 proteins, which form a positive feedback loop, is resulted from the 
stress induced by zinc supplementation. 
Six main objectives of the present studies were used to test the above hypotheses. 
Firstly, to measure the Gadd45, p53, p38 mRNA abundances in ZD, ZN, ZA and ZS; 
Secondly, to quantify protein levels of Gadd45, p53 and p38 MAPK in NHBE cells 
cultured under different zinc concentrations; Thirdly, to study the influence of Gadd45 
siRNA on the expression level of active form of p38 MAPK (phospho-p38) and p53 
(phospho-p53); Fourthly, to investigate the influence of knocking down Gadd45 
expression by RNA interference on G2/M progression in NHBE cells; Fifthly, to examine 
the effect of suppressing p53 transactivation activity by Pifithrin on the transcriptional 
and translational expression of Gadd45, the level of CDK1/Cyclin B1 complex, and 
G2/M progression in NHBE cells. Sixthly, to establish the influence of suppressing p38 
MAPK by dominant negative and inhibitor SB202190 on the expression of Gadd45, 
phosphorylation of p53, cellular levels of CDK1/Cyclin B1 complex, distribution of 







Experiments were designed usi es to uncover the underlining 
mechanisms responsible for the reduction in 
progression in ZS NHBE cells. Cells were cultured for one passage in different 
concentrations of zinc: <0.4 
in culture medium; 16 μM (ZA) as normal human plasma zinc level; and 32 μM (ZS) as 
the high end of plasma zinc level attainable by oral supplementation. The cell cycle 
progression was examined by Flow Cytometry. The expressions of p38 MAPK, p53 and 
Gadd45 mRNA abundance in zinc status were measured by RNase Protection Assay 
(RPA). The protein levels of p38 MAPK, p53, Gadd45, phospho-p53 (ser15), 
phospho-p38 MAPK were analyzed by Western Blot. Suppression of Gadd45 was 
accomplished by the usage of small interference RNA (siRNA) targeting Gadd45 mRNA. 
The effect of siRNA suppression on Gadd45 was examined by measurement of Gadd45 
protein, cell cycle progression, phospho-p53 protein, and phospho-p38 MAPK. The 
dependency of Gadd45 and p53 expression and G2/M progression on the activation of 
p38 MAPK was examined not only by administration of p38 MAPK (SB202190) protein 
inhibitor, but also by applying p38 MAPK dominant negatives, to suppress the expression 
of p38 MAPK. p38 MAPK kinase activity was measured by non-radioactive kinase assay. 
The protein levels of CDK1 and Cyclin B1 complex were measured by 
immunoprecipitation. Gadd45 protein level, cell cycle progression, and the levels of 
CDK1 and Cyclin B1 complex, were measured after suppressing p38 MAPK. 
Furthermore, the induction of Gadd45 in the p53-dependent pathway was investigated by 
suppressing p53 transactivation activity with protein inhibitor Pifithrin.  
 
ng different approach
cell growth and delay in G2/M cell cycle 
μM (ZD) as severe zinc deficient; 4 μM as normal zinc level 
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A better understanding of the mechanisms involved in the protection of normal cells  
from zinc cytotoxicity is essential for the identification of potential targets, such as 
Gadd45, p53 and p38 MAPK, and may contribute to the development of future 







Minerals are inorganic substances that exist naturally in the earth. Many of them are 
necessary for good health, and are termed as essential nutrients. Minerals are found in 
bone, tissue, blood, and nerve cells, and are divided into two groups, namely 
macrominerals and microminerals. Macrominerals are necessary for human health which 
is needed in relatively large more than 100mg/day. Macrominearals includes sodium, 
calcium, potassium, chloride, phosphorus, magnesium and sulphur. Microminerals are 
needed in small amounts of less than 100mg/day. Microminerals include iron, zinc, 
copper, selenium, manganese, molybdenum, chromium, bromine, fluorine and cobalt.  
Zinc belongs to group II B of the transition elements of the periodic table. Its atomic 
number is 30 and atomic weight is 65.39. It was firstly isolated in 1746 by the chemist S. 
Margraaf and was named by the Swiss alchemist Theophrastus Bombastus von 
Hohenheim. A divalent ion under physiological conditions, zinc (~3 g) is the second most 
abundant trace element in the body after Fe (4 g) and is considerably more abundant than 
Cu (0.1 g; Solomons, 1988). Zinc is present in all organs, tissues, and body fluids with 
the highest levels in muscles, liver, kidneys, bones and prostate. Approximately 90% of 
total body zinc is found in skeletal muscle and bone. Over 95% of total body zinc is 
bound to proteins within cells and cell membranes. Most of the zinc (7
 
 
5% to 88%) in 
blood is found in the red blood cell zinc metalloenzyme carbonic anhydrase. In the 
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plasm
meostasis, and immune 
defenses. Zinc deficiency can result in stunted growth, immune malfunction, increase 
infection susceptibility, hypogonadism, anorexia, diarrhea, weight loss, skin changes, 
oligospermia, delayed wound healing, neural tube defects of the fetus, alopecia, mental 
lethargy and increased risk for abortion. 
Zinc is an essential element in human and animal nutrition with a wide range of 
biological roles. Zinc plays catalytic, structural or regulatory roles in the more than 300 
zinc metalloenzymes that have been identified in biological processes. These enzymes are 
involved in nucleic acid, protein metabolism and production of energy. Zinc plays a 
structural role in zinc finger motif. Zinc fingers are used by transcription factors for 
interacting with DNA and regulation of genes. Another structural role of zinc is in the 
maintenance of the integrity of biological membranes resulting in their protection against 
oxidative injury.  
Zinc is essential for good health. The recommended daily allowance (RDA) of zinc 
is 8 mg/day for women and 11 mg/day for men.  Daily essential intake is dependent on 
food, and the daily requirement depends on gender, age, and general status. Women in 
pregnancy and in lactation have a higher zinc requirement therefore the RDA of zinc 
increases for lactated women to 12 mg/day (Walsh et al., 1990; Simon-Hettich et al., 
2001; Prasad et al., 1995). 
In developed countries, zinc deficiency Moderate to severe zinc deficiency is rare. 
a, approximately 18% of zinc is bound to alpha-2-macroglobulin, 80% to albumin 
and 2% to such proteins as transferrin and ceruloplasmin. 
Zinc is vital play a role in physiological processes involves in reproduction, 
development, dark vision adaptation, olfactory activity, insulin ho
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But people are at risk for mild ever, it is highly prevalent in 
developing countries. Several diseases and situations including the autosomal recessive 
isease acrodermatitis enteropathica, alcoholism, malabsorption, thermal burns, total 
trition without zinc supplementation and certain drugs, such as diuretics, 








o inc deficiency. In many of the elderly, zinc intake may be suboptimal, and if 
compounded with certain drugs and diseases, can lead to mild or even moderate zinc 
deficiency. 
Zinc is an essential dietary factor that mediates a wide range of physiological 
processes (Vallee & Falchuk, 1993). The influence of zinc on the respiratory system is 
relatively unknown. Zinc has numerous properties which enable it to modulate the 
function in airway epithelium and the cells that interact with this tissue which includes: 
fibroblasts that mediate production of collagen and other extracellular matrix protein
co et al., 2004); immunoregulatory cells (T and B lymphocytes, macrophages, and 
antigen-presenting dendritic cells (Stumbles, 1999); and inflammatory cells such as 
eosinophils, neutrophils, and mast cells (Cohn et al., 2004).  
The human body does not store zinc and a constant dietary intake is necessary. Zinc 
can be obtained from red meat and animal proteins which have a high content of zinc that 
is bound to ligands capable of facilitating zinc absorption (Solomons, 1988). Other 
sources of zinc are seafood, dairy foods, cereals, and nuts (Dreosti, 1993). Most 
vegetables are not good sources of zinc due to the presence of phytate which chelates 
zinc and inhibits its absorption (Arsenault & Brown, 2003). Diets which are low in 
animal protein and rich in phytate contribute to the high incidence of zinc deficiency in 
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many developing countries. Another cause of human primary zinc deficiency can be low 
zinc content of soils on which cows are raised (Lambein et al., 1994). Inadequate intake 
of zi
ly and is mainly responsible for housekeeping 
func
n in cells and tissues involved in secretion, including the prostatic 
epith
nc is accompanied by a number of clinical manifestations. In addition, excess of zinc 
interferes with macromolecular synthesis and function and is cytotoxic.  
Zinc balance is maintained through regulated intestinal uptake, fecal excretion, and 
renal reabsorption (Hambidge & Krebs, 2001). The bulk of body zinc is tightly bound 
within cellular metalloenzymes and zinc finger proteins (Vallee & Falchuk, 1993). This 
fixed pool of zinc turns over very slow
tions in cellular metabolism and gene expression. The remaining labile zinc is around 
10–15% which comprises of more dynamic pools that are readily depleted in Zinc 
deficiency. While fixed Zinc is distributed uniformly throughout the body, and labile zinc 
is concentrated in certain tissues and within specific regions within tissues. Labile zinc is 
usually sequestered in membrane-enclosed organelles including vesicles, granules and 
Golgi apparatus because labile zinc is potentially toxic to many sulphydryl-dependent 
cytoplasmic enzymes (Palmiter et al., 1996a). Abundant levels of labile zinc are 
predominantly see
elium (secretion of seminal zinc), pancreatic islets (secretion of insulin and 
glucagon), certain presynaptic neurons (secretion of glutamate), and mast cells (secretion 






Homeostasis of zinc 
Zinc homeostasis is maintained in the gastrointestinal system by the process of 
absorption of exogenous zinc as well as gastrointestinal secretion and excretion of 
endogenous zinc (Adamoli et al., 2001; Krebs et al., 2000). 
The primary site of absorption of exogenous zinc in humans is the distal duodenum 
and jejunum. Absorption studies in animal models indicate an inverse relationship 
between proximal percentage absorption and dietary intakes (Adamoli et al., 2001; Krebs 
et al., 2000). Free zinc forms complexes with ligands, such as amino acids, phosphates, 
and 
 a positive effect on zinc 
abso
other organic acids.  These complexes are more easily absorbed than zinc ions 
(Adamoli et al., 2001; Krebs et al., 2000).  
Inositol hexaphosphates and pentaphosphates (phytic acid) bind zinc and form 
poorly soluble complexes that results in reduced absorption of zinc. Phytate is present in 
staple foods includes cereals, corn, and rice, which exerts a highly negative effect on zinc 
absorption. Iron and cadmium can also have an adverse effect on zinc absorption (Krebs 
et al., 2000; Lonnerdal et al., 2000).  
Although the amount of protein in a meal produces
rption, individual proteins may act differently. For instances, casein has a modest 
inhibitory effect on zinc absorption compared with other proteins sources. Amino acids, 
such as histidine and methionine, and low molecular weight complexing agents, such as 
EDTA and organic acid (citrate), are known to exert a positive effect on zinc absorption, 
and they have been used in zinc supplementation (Krebs et al., 2000; Lonnerdal et al., 
2000; Sandstrom et al., 1989). 
 
 9
Table 1. Zinc concentration in foods 








Milk products 12 
Cereals 9.9 
Sugars and preserves 5.5 
Green vegetables 3.9 
Potatoes 3.3 
Fresh fruit 0.85 






Canned vegetables 4.2 
Milk 3.9 
Other vegetables 2.4 
Fruit products 0.63 
Beverages 0.14 




































Cell replication and differentiation of:  
osteoblasts and fibroblasts. 
Cellular transportation and synthesis of: 
alkaline phosphatase 
Somatomedin-c, osterocakin, collagen, 









GH: synthesis, secretion 
Somatomedin-c, production in liver 
Somatomedin-c, activation in bone cartilages
Other hormones: testosterone, thyroid 
hormones, insulin and vitamine D. 
Chemostaxis of neutrophil granulocytes 
Action of T cells; Action on B cells 
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2.2. Airway Epithelium 
Introduction 
Airway epithelium is the physical barrier that separates the airway connective tissue 
oth muscle from the airway lu contents. The smooth muscle may contain a 
ntially noxious substances such as allergens, dust, and gaseous pollutants. 
sence of an intact epithelial barrier, these potential hazardous substances can 
scle contraction and initiate an inflammatory reaction in the 
cosa (Folkerts & N mp, 1998; Thompson, 1998; Holgate et al., 
rway epithelium comprises up to 8 different cell types: ciliated columnar cells 
inant cell type), secretary cells (goblet cells, serous cells, clara cells, small 
le cells, brush cells, an roendocrine cells) and basal cells (Takizawa, 
1990). The basal cells serve to anchor columnar cells to the basement membrane, and as 
precursors of columnar and secretary airway epithelium cells (Ayers & Jeffery, 1988). To 
provide energy for ciliary beating, the apical cytoplasm contains abundant mitochondria 
ial cells secrete high molecular weight 
mucopolysaccharides (mucin) into the periciliary or epithelial lining fluid (ELF). Foreign 
particles trapped in the mucin are cleared by the beating of the cilia in a process known as 
mucociliary clearance (Rogers, 2004). Amongst other factors secreted into ELF are 
anti-bacterial agents such as lysozyme, collectins, and β-defensins (Cole et al., 1999; Van 
de W tering et al., 2004), and anti-oxidants such as glutathione and ascorbic acid (Deaton 
et al., 2004). Therefore, the airway epithelium plays a critical role in maintaining sterile, 
undamaged airway tracts through clearance of irritants and other noxious particles. Apart 
from these protective functions, the airway epithelium regulates airway physiology 







mucous granu d neu




through production of smooth muscle relaxant factors such as prostaglandin E2 and nitric 
xide and enzymes which catabolize smooth muscle contractile agonists (Holgate et al., 
leased from inflammatory cells and from dust mites (Asokananthan et al., 2002), and by 
active oxygen species (ROS), which may arise from endogenous sources include 
itochondria, as well as from exogenous sources e.g., inflammatory cells and cigarette 
oke (Truong-Tran et al., 2001a). Susceptibility of airway epithelium to damage may, in 
art be genetically determined, since only a proportion of smokers appear to be 
sceptible to the airway damage that results in physiological decline in airway function 
letcher & Peto, 1977). The role of abnormal repair mechanisms in the response to 
igarette smoke is yet to be determined. Damage to airway epithelium is a significant 
ctor also in the pathogenesis of a number of chronic inflammatory airway diseases 
cluding asthma, chronic obstructive pulmonary disease, and cystic fibrosis. As a 
onsequence of repeated damage and repair, the epithelium becomes remodeled and 
ver-produces mucin, growth factors, and pro-inflammatory cytokines such as TNFa, 
hich act to further aggravate the inflammation and resulting airway 
yper-responsiveness (Woolcock & Barnes, 1992). Apoptosis, a mechanism of cell death 
hereby the cell fragments by a controlled, energy-dependent process into apoptotic 
bodies, is important for cell turnover in ep elial tissues, including airway epithelium 
(Rosenblatt et al., 2001; Kerr, 2002). Airway epithelium cells are susceptible to apoptosis 
by various stimuli including corticosteroids, pro-inflammatory cytokines, and ROS (Wen 
et al., 1997; Dorscheid et al., 2001; Bucchieri et al., 2002). Apoptotic airway epithelium 
and biochemical changes which facilitate their rapid 
o

















cells undergo morphological 
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clearance by phagocytosis or by shedding into the lumen.. These dying cells are removed 
allowed or coughed up. Important effector 
proteins driving apoptosis are the caspase family of enzymes (especially caspases-3 and 
-6) which exist in healthy cells as inactive precursors (pro-caspases) and become active in 
cells about to apoptosis (Salvesen & Abrams, 2004). This regional distribution of 
procaspase-3 may have important implications for spatio-temporal aspects of caspase 
activation and apoptosis in these cells, since the initial damage leading to apoptosis may 
be more likely to occur at the luminal surface from contact with inhaled pollutants, 
allergens, and oxidants. In addition, there may be high local concentrations of ROS 
released from apical mitochondria as a by-product of energy formation for ciliary beating. 
The localization of procaspase-3 to the apical cytoplasm could therefore provide an early 
response mechanism to luminal toxins, allowing the airway epithelium cells to die in a 
controlled manner by apoptosis. While apoptosis of damaged airway epithelium cells is 
likely to be beneficial in the normal respiratory tract, excessive and inappropriate 








by mucociliary transport and are either sw
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2.3. Zinc in airway epithelium cells 
Localization of zinc 
There is likely to be a considerable flux of zinc into and across airway epithelium. 
Firstly, there is zinc uptake at the basolateral surface from zinc -containing plasma 
albumin in sub-epithelial capillaries. From studies in other tissues, it is likely that the 
hZIP family of transporters is involved in the plasma membrane uptake, and the zinc is 
packaged in cytoplasmic vesicles which migrate to the perinuclear region and apical 
cytoplasm. Studies have shown strong apical immunolocalization of zinc transporter 4 
(ZnT4) in ciliated human bronchial and nasal epithelial cells, as well as weaker 
localization to the basolateral plasma membrane. ZnT4 has not previously been found to 
Studies using fluorescent dye Zinquin have shown that airway epithelium is rich in 
labile zinc. Zinquin fluorescence was most intense at the luminal surface of the airway 
epithelium in cryostat sections of sheep, pig, and mouse trachea and lung (Truong-Tran et 
al., 2000; Truong-Tran et al., 2002). The distribution of zinc was investigated after 
obtaining single cell suspensions of ciliated columnar airway epithelial cells prepared by 
tracheobronchial or nasal brushing. In more than 95% of these cells (sheep or human), 
Zinquin fluorescence was most intense in the apical cytoplasm (Carter et al., 2002). In 
approximately 60% of the cells, there was a prominent, diffuse apical fluorescence that 
may largely be due to zinc in cytoplasmic vesicles, some perinuclear and others are in 
proximity to the apical membrane.  
 
Zinc turnover in airway epithelium  
mediate cellular zinc uptake in other types of cell. Rather since ZnT4 is largely localized 
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to the membranes of cytoplasmic vesicles (Murgia et al., 1999; Ranaldi et al., 2002), it 
may play a primary role in vesicular uptake of zinc and its translocation to the apical 
cytoplasm. Here zinc may be released from vesicles and incorporated into the 
microtubules of basal bodies (Truong-Tran et al., 2000). Other zinc may be disposed 
around the apical mitochondria or interact with cytoplasmic metalloproteins in this region 
such as procaspase-3 (zinc -regulated protein) and Cu/Zn superoxide dismutase (Cu/Zn 
SOD) (Carter et al., 2002). At least some of the zinc may be destined for secretion into 
epithelial lining fluid (ELF). Measurements of the zinc content of this fluid should be 
informative. While most airway epithelium zinc likely derives from sub-epithelial 
capillaries, we cannot exclude that some zinc enters at the mucosal surface of the lumen 
by reabsorption of secreted zinc. Certainly, polarized epithelial cells can internalize 
macromolecules across either the apical or basolateral membranes (Apodaca, 2001).  
 
Functional role of zinc in Airway epithelium 
Zinc has potential cytoprotective, secretory, growth-promoting, and signaling 
functions not only for airway epithelium but also for the cells which interact with this 
tissue.  
Signal transduction of zinc  
he concept that zinc ions may participate, like calcium ions, as second messengers 
in cell signaling was first proposed two decades ago (Williams, 1984), however, evidence 
for supporting this concept is only now beginning to emerge. Zinc ions have now been 




tyrosine kinase and phosphatidylinositol 3-kinase/Akt pathways and suppressing protein 
Korichneva et al., 2002; Wu et al., 2003). 
For example, Wu et al. (2003) demonstrated that zinc supplementation of primary human 
airway epithelium in vitro and rat airway epithelium in vivo resulted in 
proteasome-mediated degradation and loss of function of PTEN, a tumor suppressor 
protein which dephosphorylates PIP3 and negatively regulates the phosphatidylinositol 3- 
kinase/Akt pathway, thereby stimulating cell growth and suppressing apoptosis in airway 
epithelium. Two further studies are of particular relevance to airway smooth muscle 
contraction. Firstly, zinc concentration as low as 1 μM was found to bridge two 
trans-membrane domains of the beta2 adrenoreceptor, resulting in a positive allosteric 
modulation of agonist binding (Swaminath et al., 2003). This finding is interesting for 
two reasons. Agonists of beta 2 adrenoreceptor relax airway smooth muscle and are 
widely used bronchodilators in the treatment of asthma. Moreover, at a pharmacological 
level, there may be benefit in adding zinc with bronchodilators. At a physiological level, 
a fall in zinc levels in airways below a certain threshold may enhance 
broncho-constriction through an imbalance in sympathetic cholinergic systems. 
Furthermore, zinc may influence bronchoconstriction. 
 
Antioxidant activity of zinc 
Airway epithelium is vulnerable to a range of oxidants derived internally or 
externally from atmospheric oxidants and from inflammatory cells during acute or 
chronic inflammation of the airways (Wright et al., 1994). To combat these oxidants, 
airway epithelium and its secretions contain a variety of anti-oxidants including catalase, 
kinase C (Bruinsma et al., 2002; Hajnal, 2002; 
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vitamins C and E, glutathione, and two forms of superoxide dismutase (Wright et al., 
1994). Using protein magnetic resonance imaging to monitor hyperoxia-induced damage 
in rats, studies showed that in vivo zinc deficiency results in increased oxidative stress in 
the lung (Taylor et al. 1997). When zinc was repleted in the diet, damage from hyperoxia 
exposure was prevented. Some of the anti-oxidant effects of zinc are due to stabilization 
of sulphydryls and membrane lipids (Powell, 2000; Carter et al., 2002) and suppression 
of nitric oxide production (Cui et al., 1999). Zinc is also a component of a major 
anti-oxidant enzyme in airway epithelium, Cu/Zn SOD. Larsen et al. (2000) demonstrated 
the importance of Cu/Zn SOD by showing that transgenic mice with elevated levels of 
this enzyme in the lungs were more resistant to allergen-induced hyper-responsiveness 
than wild-type mice. Using immunofluorescence in human bronchial and sheep tracheal 
airway epithelial cells, studies have shown that Cu/Zn SOD is localized to the same 
apical region as labile zinc (Carter et al., 2002). The zinc in this metalloenzyme appears 
 may be reactive with Zinquin. 
Alth
nt cellular damage (Estevez et al., 1999). 
n and cell membranes of airway epithelium 
to be readily exchangeable (Estevez et al., 1999) and
ough the role of zinc in Cu/Zn SOD is unclear, its removal is known to promote 
catalysis of peroxynitrite-mediated tyrosine nitration, resulting in protein oxidation and 
conseque
 
Zinc stabilizes the cytoskeleto
Zinc deficiency alters the lipid composition, enzyme activity, and protein 
composition of the plasma membrane and associated cytoskeleton thereby increasing 
membrane permeability (Hennig et al. 1999).  Studies are needed to determine whether 
zinc deficiency leads to an increase in airway epithelium permeability and whether 
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altered airway epithelium zinc levels are a factor in increased permeability of inflamed 
airways. The prominent labeling of the ciliary apparatus by Zinquin may indicate another 
role for zinc in the formation, integrity, or beating of cilia. Tubulin is known to bind zinc 
(Serrano et al., 1988) and contains sulphydryls that are susceptible to oxidation 
(Roychowdhury et al., 2000). Since there is evidence that both ciliary beat frequency and 
integrity of cilia are reduced by cigarette smoke and other oxidants (Pettersson et al., 
1985; Sisson et al., 1994), which may affect one or more of these sulphydryls may be 
critical. 
 
Effects of zinc supplementation in airway epithelium 
There have been no detailed studies of zinc levels in airway inflammatory disorders. 
However, there has been some interest in the relationship between zinc deficiency and 
cystic fibrosis, an airway disease that, like asthma, is characterized by hypersecretion of 
mucin into the airway lumen. The first indications that infants with cystic fibrosis may 
have abnormalities in zinc homeostasis emerged from analysis of plasma zinc 
concentrations from the Colorado Newborn Screening Program. This survey suggested 
that zinc status was frequently suboptimal by 6 weeks of age in infants with cystic 
fibrosis (Krebs et al., 2000). Nearly 30% had plasma zinc concentrations below the 
using pancreatic enzyme replacement resulted in a 
norm
normal range and therapy 
alization of plasma zinc. A conclusion from these studies was that plasma zinc 
concentrations should be evaluated in infants or children with cystic fibrosis, especially 
those who have poor growth, and that zinc should be included among the specific 
micronutrients in the management of this disease. A recent study has provided new 
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insight into the role of zinc in this disease. In the presence of ATP, zinc (at a relatively 
low concentration of 20 μM) was shown to restore chloride ion secretion in cellular and 
animal models of cystic fibrosis. Zinc was proposed to bound to and activated a class of 
purinergic receptor channels stimulating an increase in intracellular Ca2+ ions, which 
enables the by-passing of the defective cystic fibrosis transmembrane conductance 
regulator (CFTR) chloride channels and triggering of Ca2+-dependent chloride secretion 
(Zsembery et al., 2004). This is an important study, not only for its implications for 
therapy of cystic fibrosis, but also because it shows for the first time that, when applied at 
the apical surface, extracellular zinc can modulate airway epithelium function. While 
animal models of airway inflammation are necessary to more fully explore the 
mechanisms by which zinc supplementation affects parameters such as airway epithelium 
apoptosis, inflammation, and airway hyper-responsiveness (AHR), ultimately, 
double-blinded clinical trials of zinc supplementation in asthma are required. Ideally, 
maintenance of body zinc levels should be achieved by ensuring proper zinc nutrition 
with a healthy balanced diet containing foods such as red meat, dried beans, dairy 
products, and whole grains, especially from regions of normal soil zinc concentrations. 
zinc -fortified cereals are now a major source of zinc for young children (Arsenault & 
Brown, 2003). However, there is a need for supplementation with zinc when short-term 
th variable 
succ
measures need to be put in place quickly. Supplementation has been used wi
ess in at least one airway disease, cystic fibrosis (Krebs et al., 2000). Issues to be 
considered in such trials are the optimal routes of administration and the best forms of 
zinc supplement to use for the airways. Zinc sulphate and zinc gluconate have been the 
most widely used oral forms. Oral zinc supplements have proven to be effective in a 
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number of conditions affecting distant organs and tissues (Pories et al., 1967).  Side 
effects of oral zinc are nausea, dyspepsia, and the unpleasant metallic taste. According to 
WHO guidelines, the safe upper limits for infants and very young children are 13 mg / 
day, for older children and adolescents 20–30 mg/day, and for adults 50 mg/day; these are 
based on an oral dose of 1 mg zinc /kg/day (Arsenault & Brown, 2003). Long-term 
effects of chronic zinc supplementation, however, can impair Cu and Fe absorption. In 
rats, a high ratio of ingested zinc to Cu results in hypercholesterolemia but this was not 
seen in a study of human rheumatoid arthritis patients receiving recommended doses of 
zinc supplements for long periods (Honkanen et al., 1991). Depressed immunity, 
il chemotaxis, and phagocytosis, 
was 
especially diminished lymphocyte proliferation, neutroph
seen in humans receiving very high doses 100–300 mg zinc /day (Shankar & Prasad, 
1998). In addition to oral administration, tissue zinc concentrations can be increased 
locally, as by topical zinc oxide creams for the skin (Salgueiro et al., 2002) and zinc 
sulphate enemas for the bowel (Chen et al., 1999). The first attempt to introduce zinc into 
the airways for therapeutic purposes was that by Franklin (1931) who used electrolysis to 
introduce aqueous zinc sulphate into nasal epithelium and alleviate symptoms in subjects 
with hay fever. Novick et al. (1997) suggested that oral zinc gluconate lozenges directly 
increase nasal zinc levels via increased salivary zinc concentrations and subsequent 
transfer of zinc to the nasal cavity. They proposed that this route mediated the capacity of 
zinc gluconate to suppress rhinovirus-induced inflammation in the respiratory tract as 
well as the anecdotally reported beneficial effects of zinc gluconate in allergic rhinitis. In 
1977, Cho and his colleagues used zinc sulphate-containing aerosols to prevent 
allergen-induced bronchoconstriction in sensitized guinea pigs. The safe doses and the 
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likely side effects of zinc aerosols need to be identified, especially in light of known toxic 
effects to airways of high does of inhaled zinc in some zinc-related occupations and the 
loss of olfactory sensations in animals given nasal zinc irrigations (McBride et al., 2003).  
 
Zinc toxicity in the airways 
In some mining industries and during galvaniz tion of iron, welding, and 
manufacture of brass, zinc may reach toxic levels in the air and pose a significant health 
risk to chronically exposed workers (Merchant & Webby, 2001). zinc toxicity is 
associated with an acute febrile illness, characterized by chills, fever, and myalgias, 
which result from an acute respiratory tract inflammation accompanied by bronchial 
hyper-responsiveness. There is no specific treatment and symptoms usually resolve over 
a period of 36–48 hr (Fuortes & Schenck, 2000). In one study, more than one in four 
welders had increased polymorphonuclear leukocytes in their bronchoalveolar lavage 
fluid, suggestive of pulmonary inflammation (Blanc et al., 1991). There are also reports 
of zinc fume fever leading to asthma. In one subject, who was chronically exposed to 
zinc during galvanization, inhalation of a solution of ZnSO4 induced a fall in Forced 
Expiratory Volume in the first second (FEV1) of 23% (Malo et al., 1993).  
A considerable amount of scientific data has extensively demonstrated the essential 
role played by zinc for human health, these data have been derived from the publications 
of Salgueiro (Salgueiro et al., 2002), Hambidge (Hambidge et al., 2000), and Prasad 
(Prasad et al., 1996). Research should now focus on possible links between zinc and 





Cancer is a class of diseases or disorders characterized by uncontrolled division of 
cells and the ability of these cells to spread, either by direct growth into adjacent tissue 
through invasion, or by implantation into distant sites by metastasis where cancer cells 
are transported through the bloodstream or lymphatic system. Cancer may affect people 
at all ages, but risk tends to increase with age. It is one of the principal causes of death in 
developed countries. In the USA and other developed countries, cancer is presently 
responsible for about 25% of all deaths (Jemal et al., 2005). Every year, 0.5% of the 
population is diagnosed with cancer. Table 2 is the statistics for adults in the United States 
in 2005. 
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Most Common Causes of Death 
Prostate Cancer (33%
Lung Cancer (31%) 
) Lung Cancer (31%) 
Prostate Cancer (10%) 
Colorectal Cancer (10%) Colorectal Cancer (10%) 
Bladder Cancer (7%) Pancreatic Cancer (5%) 
Cutaneous melanoma (5%) Leukemia (4%) 
 
Female 
Most Common Causes of Death 
Breast Cancer (32%) Lung Cancer (27%) 
Lung Cancer (12%) Breast Cancer (15%) 
Colorectal Cancer (11%) Colorectal Cancer (10%) 
Non-Hodgkin Lymphoma (4%) Pancreatic Cancer (6%) 
Endometrical Cancer (6%) Ovarian Cancer (6%) 
 

























Lung cancer is the malignant transformation and expansion of lung tissue, and is the 
most
 of the disease. 
Exposure to carcinogens, such as those present in tobacco smoke, immediately 
causes cumulative changes to the tissue lining the bronchi of the lungs (the bronchial 
mucous membrane) and more tissue gets damaged until a tumour develops. Most of the 
causes of lung cancer are enviromental factors: carcinogens such as those in cigarette 
smoke, radiation exposure, enetic susceptibility, and viral infection. 
In the United States, smoking is estimated to account for 87% of lung cancer cases 
(90% in men and 79% in women). Cigarette smoke contains 19 known carcinogens 
(Koop, 2006) including radioisotopes from the radon decay sequence, nitrosamine, and 
benzopyrene. Additionally, nicotine appears to depress the immune response to malignant 
growths in exposed tissue. The length of time a person continues to smoke as well as the 
amount smoked increases the person's chances of developing lung cancer. More recent 
work has shown that, across the developed world, almost 90% of lung cancer deaths are 
caused by smoking (Peto et al., 1994). 
 lethal of all cancers worldwide, responsible for 1.2 million deaths annually. It is 
caused mainly by cigarette smoking, and predominantly affected men, but with increased 
smoking among women, it is now the leading cause cancer death in women (American 
Cancer Society, 2006). 
There are two main types of lung cancer categorized by the size and appearance of 
the malignant cells seen by a histopathologist under a microscope: non-small cell (80%) 
and small-cell (roughly 20%) lung cancer. This classification although based on simple 
pathomorphological criteria has very important implications for clinical management and 
prognosis
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Lung cancer is the second most commonly occurring form of cancer in most western 
and it is the leading cancer-related cause of death for men and women. In the 
S, 175,000 new cases are expected in 2006 (National Lung Cancer Partnership, 2005), 
and 90,700 in men and 80,000 in wo ng cancer was extremely rare prior to the 
advent of cigaret , mal  made up only 1% of all 
cancers seen at au  10 0s (Witschi et al., 2001). 
Case reports in the medical literature numb dwide in 1912 (Adler et al, 
2005). Not all cas  ar  role of passive smoking is 
increasingly bein  a risk cancer, leading to policy 
interventions to d ur thers' tobacco smoke.  
 
Lung cancer and
Cancers are mostly derived from epithelial cells that eventually differentiate, and 
ost of the lung cancers deveoloped from the bronchial epithelial cells (Green et al, 1977, 
uerbach et al., 1961). Normal human bronchial epithelial cells (NHBE) are therefore a 
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ered only 374 worl
es of lung cancer e due to smoking, but the
g recognized as factor for lung 
ecrease undesired expos e of non-smokers to o


















2.5. Growth Arrest and DNA Damage inducible gene (Gadd45) 
 
The growth arrest and DNA
Introduction 
 damage-inducible (Gadd) gene Gadd45 is a member of 
a group of genes that are i
n mustard, melphalan, hydrogen peroxide, 
hypoxia, many cancer chem
. These cells include 
multiple m
nduced by DNA damaging agents and growth arrest signals. 
Gadd45 was initially isolated from Chinese Hamster Ovarian cells (CHO) treated with 
ultraviolet radiation based on its mRNA inducible expression. However, it was 
subsequently found to be induced by a wide spectrum of DNA-damaging agents such as 
methylmethane sulfonate (MMS), nitroge
otherapeutic drugs, ionizing radiation (IR), growth factor 
withdrawal, and medium depletion (Fornace et al., 1988; Papathannasiou et al., 1991a; 
Papathannasiou et al., 1991b; Fornace et al., 1992).  After DNA damage, Gadd45 
induction is rapid, transient and dose-dependent. Gadd45 induction by certain DNA 
damage-agents has been detected in a variety of mammalian cells
ouse cell lines, human fibroblast, human lymphoblast and multiple human 
tumor lines (Fornace et al., 1992; Fornace et al., 1989).  
Gadd45 encodes a conserved 165 amino acid protein with nuclear localization and is 
widely expressed in normal tissues, particularly in quiescent cellular populations. 
Expression of Gadd45 protein is regulated throughout the cell cycle and the levels of this 
protein are highest in G1 phase and greatly reduced during S phase (Carrie et al., 1996; 




observed either in p53-null Li-Fraumeni fibroblasts or in human cells with abnormal p53.  
Gadd45 is closely associated with genomic instability and tumorigenesis. The 
importance of Gadd45 in maintenance of genomic stability has clearly been reflected by 
the phenotypic alterations observed in Gadd45-null mice. Studies have reported that 
disruption of endogenous Gadd45 has a substantial impact on genomic instability and 
growth control (Hollander et al., 1999). Gadd45-null mice generated by gene targeting 
xhibit severe genomic instabilities, which are exemplified by aneuploidy, chromosomal 
berrations, gene amplification, centrosome amplification, abnormal mitosis, and 
ytokinesis (Hollander et al., 1999). Most strikingly, mice lacking the Gadd45 gene are 
ore susceptible to DNA damage-induced tumors, including carcinogenesis induced by 
UV radiation, ionizing radiation, and dimethylbenzanthracene (DMBA) (Hollander et al., 
uitination-mediated proteolysis and may involve the PKCdelta-dependent 
ubiquitin-proteasome pathway (Leung et al., 2001). 
Cell cycle G2/M arrest mediated by Gadd45 
Wang et al (1999) firstly showed that microinjection of the Gadd45 expression 
vector into normal human fibroblasts could block cells at the G2/M transition, which 
indicated that Gadd45 may cause cell cycle G2/M arrest (Wang et al., 1999). The 
Gadd45-mediated G2/M arrest was found to depend on wild-type p53, since no arrest was 
 






1999; Hollander et al., 2001; Hildesheim et al., 2002). After treatment with carcinogens, 
nearly twice as many Gadd45-null than wild-type mice had multiple tumors, and three 
times as many had multiple malignant tumors, suggesting that inactivation of Gadd45 
may be associated with the development of malignancy. Interestingly, in DMBA-treated 
Gadd45-null m
Gadd45 regulatory pathway: p53-dependent and p53-independent 
p53-dependent 
The signaling pathways that regulate Gadd45 expression after genotoxic stress is 
comp
cellular response (El-Deiry et al., 1998). Interestingly, Gadd45 is the only member of the 
ice, a markedly increase in female ovarian tumors and male hepatocellular 
tumors has been shown, but an increased in vascular tumors in both sexes with defective 
Gadd45 has been observed (Hollander et al., 2001). Most recently, Gadd45 has been 
found to regulate matrix metalloproteinases, whose activity promotes cell migration and 
invasion (Hildesheim et al., 2004). Thus, in addition to its role in tumorigenesis, Gadd45 
may also contribute to tumor progression. Most carcinogens are genotoxic agents that 
produce different types of DNA damage, enhanced tumorigenesis and tumor progression 
in Gadd45-null mice may result from their decreased DNA repair, disrupted cell cycle 
checkpoints, impaired signaling pathways and loss of normal growth control. 
 
lex and may involve different mechanisms according to various types of DNA 
damaging agents and different cellular genetic statuses. Upon DNA damage, p53 protein 
has been established to be stabilized and post-translationally modified probably though 
phosphorylation–acetylation cascade (Oren et al., 1999; Prives et al., 1999). The activated 
p53 in turn, up-regulates many target genes that may play roles in different aspects of 
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Gadd gene group that is frequently inducible by ionizing radiation in human cells with 
wild-type (wt) p53. After cellular exposure to IR, Gadd45 mRNA can be transcriptionally 
activated by p53 protein (Kastan et al., 1992; Zhan et al., 1994). Disruption of 
endogenous p53 by introduction of HPVE6, a p53 inhibitor that associates with p53 
utant p53 into cells, results in a 
substantial reduced Gadd45 induction following IR (Zhan et al., 1996). Moreover, 
over-
1992). Therefore, IR-induction of Gadd45 is strictly dependent on normal cellular p53 
ATM kinase appears to be involved in the regulation of Gadd45 induction by IR. 
The response of Gadd45 to IR has been established to be significantly reduced in AT 
lymphoblast lines as compared with normal lymphoblast cells (Papathanasou et al., 1991). 
Currently, the connection between Gadd45 and ATM is thought to be via the induction of 
p53 (Kastan et al., 1992). The p53-regulatory elements in Gadd45 are found to locate at 
the third intron of the gene. This putative p53-binding motif in the human and hamster 
Gadd45 gene matches the p53 consensus sequence in 19 of 20 bp in 16 of 20 bp, 
respectively (Kastan et al., 1992). Using both immunoprecipitation and gel mobility shift 
assays, wild-type but not mutant p53 protein strongly binds to this conserved element. 
Similarly, the p53-binding site in the MDM2 gene is also located at the intronic region of 
protein and promotes p53 degradation, or dominant m
expression of MDM2, a p53-targeted gene that forms an auto-regulatory feedback 
loop and keeps p53 under negative control, also abolishes IR-induction of Gadd45 (Chen 
et al., 1994). These findings are further supported by the demonstrations that mouse 
embryo fibroblasts (MEFs), derived from mice where both p53 alleles had been abolished, 
do not exhibit Gadd45 induction by IR as compared to their parental MEFs (Kastan et al., 
function.  
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the gene (Chen et al., 1994). In contrast to the Gadd45 and MDM2 genes, two other 
p53-regulated genes; p21Waf1/Cip1, a potent inhibitor of cyclin-dependent kinase, and Bax, 
a member of the Bcl-2 family that promotes apoptosis, harbor p53-binding motifs in their 
promoter regions (El-Deiry et al., 1993; Miyashita et al., 1995). 
Much of the DNA damage response is localized to a GC-rich motif in the proximal 
promoter that contains a large motif for WT1, a tumor suppressor and transcription factor 
that is known to associate with p53 physically and functionally (Maheswaran et al., 1993). 
Several lines of evidence indicate that p53 protein exists in the WT1-associated complex 
and has a synergistic effect with WT1 in the induction of the Gadd45 promoter. 
Employment of a dominant-negative p53 vector or abrogation of WT1 function by an 
antisense vector markedly reduced the responsiveness of the Gadd45 promoter to 
genotoxic stress. In addition to a strong p53-responsive motif in the intronic region of the 
Gadd45 gene, p53 may also contribute to the stress responsiveness of the Gadd45 
promoter in the absence of direct DNA binding (Zhan et al., 1996). Because of the lack of 
functional/typical p53 binding sites in the Gadd45 promoter, the participation of p53 in 
l induction of the Gadd45 promoter is likely through protein–protein 
inter
the transcriptiona
action between p53 and WT1 (Zhan et al., 1998). This finding has greatly broadened 
the known role of p53 in its downstream-targeted genes.  
In contrast to IR induction of Gadd45, which requires normal cellular p53 function, 
most DNA damaging agents and growth arrest signals (designated as non-IR treatments) 
have been found to induce Gadd45 in cells regardless of p53 status (Zhan et al., 1996). 
For example, MMS, UV or medium starvation can activate Gadd45 transcription in 
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multiple human tumor lines containing mutated or deleted p53 alleles, and 
dominant-negative mutant p53 vectors. Disruption of endogenous p53 results in reduced 
induction of Gadd45 by non-IR stress (Zhan et al., 1996). Therefore, p53 is not required 
for Gadd45 response to these non-IR agents, but may contribute to these stress responses. 
Since the promoter of Gadd45 mainly regulates Gadd45 induction by non-IR agents, the 
effect of p53 on Gadd45's response to non-IR treatments is likely mediated through p53 
interaction with WT1 protein (Zhan et al., 1998).  
In spite of the well-defined role for p53 in Gadd45 induction, the most recent 
findings have surprisingly shown that Gadd45 may play a role as an upstream effector in 
p53 stabilization following DNA damage (Jin et al., 2003; Bulavin et al., 2003). This 
Gadd45 function requires activation of p38 kinase, but not JNK or ERK kinases (Bulavin 
et al., 2003. Therefore, Gadd45, along with p38, appears to form a positive feedback 
signal in the activation of the p53 pathway. 
Tong et al. (2001) have recently demonstrated that activation of JNK and ERK 
pathways, but not p38, is involved in regulating the UV induction of the Gadd45 
promoter. Over expression of JNK1, Raf-1, or MEKK1, which are upstream activators 
involved in the ERK and JNK pathways, was observed to strongly activate the Gadd45 
promoter in a p53-independent manner. Interestingly, the MAP kinase activation on the 
Gadd45 promoter appears to be mediated through the OCT-1, and disruption of the 
OCT-1 and CAAT1 sites resulted in abrogation of Gadd45 activation following 
expression of JNK1, Raf-1, or MEKK1 (Tong et al., 2001). Collectively, the involvement 
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of MAP kinases in the activation of the Gadd45 promoter has highlighted the complexity 
of the signaling pathways in Gadd45 induction following genotoxic stress. 
 
Interaction of CDK1 with Gadd45  
tenuate the Gadd45-mediated 
G2/M arrest and growth suppression. Taken all together, following DNA damage 
treat
The physiological role of Gadd45 in G2/M arrest is associated with its inhibition of 
CDK1/cyclin B1, a protein complex required for G2/M transition during cell cycle 
progression. Importantly, Gadd45 inhibition of CDK1 kinase activity differs from Wee1, 
Mik1 or Myt1, which act on CDK1 inhibitory phosphorylation. Gadd45 physically 
interacts with CDK1 kinase, but not cyclin B1, and reduces the CDK1/cyclin B1 complex 
formation. Such reduction of the CDK1 and Cyclin B1 complex formation results in 
altered subcellular localization of cyclin B1 and suppression of CDK1/cyclin B1 activity 
(Zhan et al., 1999; Jin et al., 2000; Jin et al., 2002).  Jin et al. (2002) reported that 
inducible expression of Gadd45 protein reduces protein levels of cyclin B1 in the nucleus, 
but has no effect on phosphorylation status for Cdc25C and Chk1 (Jin et al., 2002). 
Therefore, the suppressive property of Gadd45 on CDK1 kinase activity is mainly due to 
its physical disruption of the CDK1/cyclin B1 complex. In agreement with these 
observations, increased expression of cyclin B1 can at
ment or growth arrest signals, p53 functions as a transcription factor to up-regulate 
the expression of Gadd45. Induced Gadd45 protein interacts with CDK1 kinase and in 
turn reduces the CDK1/cyclin B1 complex formation. This “free” cyclin B1 protein is 
likely exported from the nucleus and pumped into the cytoplasmic compartment, and 
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subject to ubiquitination-mediated protein degradation. Through this machinery, Gadd45 
inhibits CDK1 kinase activity and arrests cells at the G2/M transition.  
The CDK1-binding domain of Gadd45 has been located at the central region of this 
protein (amino acids 65–84). The CDK1-binding domain of Gadd45 is also required for 
Gadd45 inhibition of CDK1 kinase activity. Sequence analysis of the central Gadd45 
region reveals no homology to inhibitory motifs of known cyclin-dependent kinase 
inhibitors, suggesting that the CDK1-binding or -inhibitory domain of Gadd45 is a novel 
moti
Gadd45 has no appreciative direct effect on the control of cell cycle G1-S arrest, and 
neither significantly inhibits activities of any G1 phase-related cyclin(s)/kinase(s), 
inclu
 
One of the attractive issues related to Gadd45’s biological roles is how important 
this protein is in DNA repair. The earlier study by Smith et al. (1994) has shown that 
f. Deletion of this central region in the Gadd45 protein abolishes Gadd45-mediated 
cell cycle G2/M arrest and Gadd45-induced growth suppression as well, indicating that 
cell cycle G2/M growth arrest mediated by Gadd45 is one of the major mechanisms by 
which Gadd45 suppresses cell growth (Jin et al., 2000)  
ding cyclin E/CDK2 or cyclin D1/CDK2 (Zhan et al., 1999). Over-expression of 
cyclin D1, an inhibitor of the Rb-related pathway, does not affect Gadd45-induced cell 
growth suppression although it greatly blocks p21Waf1/Cip1-induced growth inhibition 
(Zhao et al., 2000).  
Gadd45 and DNA repair 
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Gadd45 interacts with proliferating cell nuclear antigen (PCNA) and may act as a player 
in nucleotide excision repair (NER), although this issue is still controversial and needs to 
be further elucidated (Kearsey et al., 1995; Kazantsev et al., 1995). Blocking Gadd45 by 
constitutive antisense expression resulted in reduced levels of DNA repair and can 




sensitize cells to killing by UV radiation or b
ith et al., 1996; Smith et al., 2000; Smith et al., 2002). Interestingly, 
evidence reported by Carrier et al. (1999) has demonstrated that Gadd45 can interact 
directly with the core histones and destabilize histone–DNA complexes following UV 
radiation (Carrier et al., 1999). These findings imply that Gadd45 can recognize an 
altered chromatin state, bind to UV-damaged chromatin, and may modulate DNA 
accessibility to cellular proteins. Using mouse embryo fibroblasts (MEFs) lacking 
Gadd45, Smith et al. (1994) have further shown that Gadd45 affects chromatin 
remodeling of templates concurrent with DNA repair, indicating that Gadd45 may 
participate in the coupling between chromatin assembly and DNA repair. Furthermore, 
MEFs with disrupted Gadd45 display reduced survival ability after UV radiation and 
cisplatin treatment as compared to wild-type MEFs (Carrier et al., 1999). Most recently, 
Gadd45 has been reported to modulate the roles of the fork head transcription factor 







Suppression of Gadd45 alleviates the G2/M blockage and 
phosphorylation of p53 and p38 in zinc supplemented normal 
3. 1. ABSTRACT 
as normal zinc level in culture 
medium; 16 μM (ZA) as normal human plasma zinc level; and 32 μM (ZS) as the high 
end of pla
up-regulation of Gadd45 mRNA and protein expression, and blockage of G2/M cell cycle 
lized after suppression of Gadd45 by siRNA, implicating that the 
enhanced phosphorylation of these proteins were Gadd45 dependent in ZS NHBE cells.  
 
human bronchial epithelial cells 
 
 
Gadd45 plays a vital role as cellular stress sensor in the modulation of cell signal 
transduction in response to the stress. In this study, we demonstrated for the first time that 
an elevated zinc status, created by culturing cells at optimal plasma zinc concentration 
attainable by oral zinc supplementation, is cytotoxic for normal human bronchial 
epithelial (NHBE) cells. Cells were cultured for one passage in different concentrations 
of zinc: <0.4 μM (ZD) as severe zinc deficient; 4 μM 
sma zinc attained by oral supplementation. Inhibition of cell growth, 
progression were observed in ZS cells. The siRNA-mediated knocking down of Gadd45 
was found to relieve G2/M blockage in ZS cells, which indicated that the blockage was 
Gadd45 dependent. Moreover, the enhanced phosphorylations of p38 and p53 (ser15) in 
ZS cells were norma
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3.2. INTRODUCTION 
Bronchial epithelial cells are the physical barrier that separates airway connective 
tissue and smooth muscle from the airway luminal contents. In the absence of intact 
epithelial barrier, airway luminal may contain harmful substances which could initiate 
inflammatory reactions in the submucosa (Folkerts et al., 1998; Thompson et al., 1998; 
Holgate et al., 1999). Exposure to high concentrations of zinc in the air may cause 
significant health risk (Merchant et al., 2001). Zinc toxicity can cause acute respiratory 
tract inflammation together with bronchial hyper-responsiveness. Studies have shown 
that workers in mining industries had increased polymorpho-nuclear leukocytes and 
incidence of pulmonary inflammation (Blanc et al., 1991). In view of the prevalence and 
clinical significance of zinc deficiency in human populations, as well as extensive use of 
zinc supplementation in animal production and to a lesser extend in human populations, 
we have initiated studies designed to examine the influence of zinc status on the 
expression of stress inducible gene, the growth arrest and DNA damage-induced gene 
(Gadd) Gadd45, in Normal Human Bronchial Epithelial (NHBE) cells. NHBE cells have 
been selected for this study because they are more representative cell population during 
lung tissue transformation and are considered to be progenitor cells for human bronchial 
cancer. 
Gadd45 was originally identified as mRNA transcript that was rapidly induced in 
response to UV radiation (Fornace et al., 1989). Gadd45 is an ubiquitously expressed 
21kD acidic protein in response to genotoxic agent, and is involved in many biological 
processes related to maintenance of genomic stability and apoptosis. Gadd45-/- 
knock-out mice were more susceptible to DNA-damage induced tumors when subjected 
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to carcinogens (Hollander et al., 2001; Hildesheim et al., 2002). 
Overexpression of Gadd45 in tum
a  
rowth (Jin et al., 200 croinjecting Gadd45 
 found to induce G2/M cell cycle arrest (Wang et al., 1999). The 
po
(O’Prey et al., 2003), or peripheral benzodiazepine receptor-specific ligands (Sutter et al., 
protein in response to an array of stimuli (Kultz et al., 1998; Chi et al., 2004; Lu et al., 
2001; Bulavin et al., 2003). Tumor suppressor gene p53 plays an important role in the 
maintenance of genomic fidelity by controlling cell cycle checkpoints and apoptotic 
process following cell exposure to genotoxic stress. The dependence of Gadd45 induction 
on normal cellular p53 function is well established (Carrier et al., 1999). In response to 
DNA damage, Gadd45 was found to contribute to the stability of p53. 
The objectives of our study were to determine the association of increased Gadd45 
expression with the blockage of G2/M in zinc supplemented NHBE cells, and to decipher 
1999; Hollander et al., 
or cell lines was found to inhibit cell growth (Zhan et 
l., 1994). Moreover, Gadd45 induction through tet-off inducible system suppressed cell
2). Initially, over expression of Gadd45 by mig
expression vector was
im rtance of Gadd45 in G2/M regulation was further supported by findings of the 
inability of Gadd45 knock-out mice to arrest G2/M cell cycle progression after exposure 
to UV radiation. In cells under hyperosmolalitive stress, inhibition of cell cycle 
progression with Gadd45 induction, which is partially dependent on p38 kinase activity 
(Kultz et al., 1998). Various studies demonstrated a functional association between 
stress-activated mitogen-activated protein kinase pathway and Gadd45 in response to 
environmental stresses (Takekawa et al., 1998). Gadd45 induction also depends on p38 
activity in other cell types exposed to oxidative stress (Oh-Hashi et al., 2001), flavonoids 
2003). Conversely, p38 activity depends on MEKK4 activation mediated by Gadd45 
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the precise molecular mechanisms of action by suppressing Gadd45 expression to 
elucidate its functions in growth arrest and cell cycle progression in normal human cell 
type.  This study provides evidence to show that in response to the adverse effect of zinc 
supplementation, the enhanced expression of Gadd45 is involved in the blockage of 
G2/M progression and enhanced phosphorylation of tumor suppressor genes, p53 and p38 



















3.3. MATERIALS AND METHODS 
Cell culture -- NHBE cells were purchased from Cambrex Bio Science (Walkersville, 
MD). Cells were plated at 3,500 cells/cm2 in tissue culture dishes containing bronchial 
epithelial cell growth medium (BEGM), supplemented with 0.5 µg/ml epinephrine, 10 
µg/ml transferrin, 5 µg/ml insulin, 0.1 ng/ml retinoic acid, 52 µg/ml bovine pituitary 
extract, 0.5 µg/ml hydrocortisone, 0.5 pg/ml human recombinant epidermal growth factor, 
and 6.5 ng/ml triiodothyronine without antibiotics, and cultured at 37°C in a 5% CO2 
incubator. Endotoxin-free medium was used (<0.005 endotoxin units/ml). The medium 
was changed at day 1 and subsequently every 48 h. The cells were grown to 80% 
confluence for 6 days, and subcultured using trypsin-EDTA at a ratio of 1: 8 at passage 3 
for experimental zinc treatment. 
A zinc-free BEGM baseline media, in which Cambrex omitted the addition of 
ZnSO4, was used as the zinc-depleted medium.  This medium consisted of Bronchial 
Epithelial Basal Media (BEBM) supplemented with growth components, and contained 
residue amounts of zinc (<0.4 μM), as detected by flame atomic absorption 
spectrophotometry.  The zinc-free basal medium of <0.4 μM was used as the 
zinc-depleted medium (ZD). For the other four treatment groups, zinc was added to the 
media in the form of ZnSO  so that the only difference between these media was the zinc 




zinc-adequate medium (ZA) contained 16 M of ZnSO4, and the zinc-supplemented 
medium (ZS) contained 32 μM ZnSO4.  The ZN medium was used as a comparison to 
standard culture media and was used as the control group for experiments.  The ZA 
treatment was used as a representative of human plasma zinc levels, and the ZS group 
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was used to represent plasma zinc levels attainable by oral supplementation in humans. 
After NHBE cells were subcultured into one of the four corresponding groups, the cells 
were cultured overnight in ZN media before changing to their respective medium.  Cells 
were then cultured in ZD, ZN, ZA and ZS for 6 days. The cell number was determined by 
using a hemocytometer, and cell viability was assessed by trypan blue dye exclusion. Cell 
morphology was evaluated by using a phase-contrast microscope (Olympus, Tokyo, 
Japan).  
 
Cellular zinc and DNA determination -- The cells were harvested after reaching 80% 
confluence. Cells were harvested by treatment with trypsin-EDTA for 5 min in 37oC 
incubat r. Both cells and media were collected by scraping from tissue culture dishes. 
And cell suspensions were then centrifuged at 500 x g for 5 min at 4oC, and cell pellets 
were washed with phosphate-buffered saline (PBS). Cells were resuspended into 1.5ml 
PBS and sonicated for two 30 sec intervals. An aliquot of the sonicated cell suspension 
was used to measure cellular zinc content by flame atomic absorption spectrophotometry 
(Hitachi, San Jose, CA). Zinc standard solutions (Fisher, Pittsburgh, PA) ranging from 
0.05 ppm to 1.0 ppm were used to generate a linear standard curve.  The zinc content of 
the cells was determined based on these zinc reference solutions. In addition, the certified 
zinc solutions were compared to bovine Liver Standard Reference (U.S. Department of 
Commerce, National Institute of Standards, Gaithersburg, MD).  Appropriate blanks 
were employed for all measurements.  From the same sample, a small aliquot of the 
sonicated cell suspension was used to measure cellular DNA content using 
diphenylamine (William et al., 1986). Data were expressed as cellular zinc per microgram 
o
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of DNA because of the linear relationship between cellular DNA and cell number we 
 
-Radioactive In Vitro Transcription kit with T7 RNA 
poly
RNA replaced NHBE RNA indicating that digestion was complete. The PAGE gel 
previously established (William et al., 1986). 
 
RNase Protection Assay -- Total RNA was isolated from NHBE cells using the 
RNAqueous Kit (Qiagen, Valencia, CA), according to manufacturer’s instruction and the 
integrity of the RNA was verified by electrophoresis and quantified by spectrophotometry. 
The mRNA abundance of human genes including, PARP, NF-κB, TNF-β, p53, Gadd45, 
p38, p21, Brca1, PCNA, MDM2, were measured by non-radioactive RNase Protection 
Assay (Pharmingen, San Diego, CA). The human GAPDH probe was also included in the 
multi-probe and was used as house-keeping gene for normalization.  Labeled riboprobes 
were synthesized using the Non
merase (Pharmingen, San Diego, CA), and Biotin-dUTP (Roche, Alameda, CA). 
RNase Protection Assay (RPA) was performed using the Pharmingen RPA kit. Each 
sample contained 10 μg of total RNA from NHBE cells, and 2 μg of the multi-riboprobe. 
The RNA and labeled probes were co-precipitated with ammonium acetate and ethanol, 
and resuspended in hybridization buffer at 56oC for 16 h. The RNase digestion was 
performed at 30oC for 45 min, followed by inactivation with proteinase K cocktail, and 
subsequent precipitation. Protected fragments were separated by Tris-Urea 
Polyacrylamide Gel Electrophoresis (PAGE) using pre-casting gel from BioRad 
(Hercules, CA). Control samples were processed without RNase digestion, only 
full-length probes were applied. No protected bands appeared in controls, in which yeast 
resolved protected probes were transferred to nylon membrane and subjected to UV 
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crosslinking. The biotin-labeled protected cDNA transferred to the membrane were 
detected by chemiluminescent signal and visualized by X-ray film exposure. 
 
Cell Cycle Analysis -- DNA contents of cells were assayed by fluorescence-activated cell 
sorting (FACS). NHBE cells were cultured in ZD, ZN, ZA, and ZS media for one passage, 
trypsinized, washed in PBS (Ca2+, Mg2+ free), and fixed in 70% cold ethanol. Cells were 
stored at 4°C. For staining, cells were collected by centrifugation, and pellets were 
suspended in 1.0 ml propidium iodide staining solution (50 mg per ml propidium iodide, 
100 U per ml RNase in PBS), and incubated at room temperature for 1 h. Staining was 
quantitated with a FACSCalibur cytometer (Becton Dickinson, San Jose, CA). The cell 
numbers were acquired with CELLQuestPro software program (Becton Dickinson, San 
Jose, CA). Cell cycle distribution percentages of stained nuclei were calculated by using 
Modfit LT software (Verity Software House, Topsham, ME). The calibration standard 
LinearFlow Green and the DNA QC Particle kit, for verification of instrument 
performance, were purchased from Molecular Probes (Eugene, OR) and Becton 
Dickinson, respectively.  
 
Western Blot analysis -- Nuclear and cytoplasmic protein concentrations were 
determined by using the BCA kit (Pierce). Forty µg of protein were resolved on a 10% 
SDS-polyacrylamide gel electrophoresis and transferred to Hybond ECL nitrocellulose 
membrane (Amersham Pharmacia Biotech, Germany) by using a mini-transfer system 
(Bio-Rad, Hercules, CA).  Membranes were blocked with 5% nonfat dry milk in PBS-T 
(10 mM phosphate buffer pH7.3, 137 mM NaCl, 2.7 mM KCL, and 0.1% Tween 20) for 
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1 h at room temperature, prior to incubation with 1 µg/ml of primary antibody from Santa 
Cruz Biotechnology (Santa Cruz, CA), in PBS-T containing 5% nonfat milk at 4°C 




secondary antibody conjugated with horseradish peroxidase (Santa Cruz, Santa Cruz, CA) 
at room temperature for 1 h, followed by three washes in PBS-T. The protein was 
visualized by using the SuperSignal West Pico Chemiluminescent Substrate (Pierce, 
Rockford, IL). Anti-Gadd45, anti-phospho-p53, anti-phospho-p38, anti-actin and 
anti-histone H1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). 
 
siRNA transfection --RNA interference of Gadd45 was performed by using a 23 bp 
(including 2-deoxynucleotide overhang) siRNA duplex with the DNA sequence 
AAAGTCGCTACATGGATCAAT. A control siRNA specific targeting to the lucife
in DNA sequence CCACTACCTGAGCACCCAG was used as a non-silencing 
control. siRNA duplexes were synthesized from Qiagen (Valencia, CA). For cell 
transfection with siRNA, NHBE cells cultured on culture dishes at 60% confluency, and 
siRNA (600 pmol) were introduced into the cells using RNAiMAX transfection reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s recommendations. Briefly, 
cells were cultured under different zinc status in cell culture dishes, in the following 
treatments: ZD-Luciferase, ZN-Luciferase, ZS-Luciferase, ZD-Gadd45, ZN-Gadd45, and 
ZS-Gadd45. Aliquots of 600pmol of siRNA-Gadd45 or siRNA-Luciferase were diluted 
with Opti-MEM medium (Invitrogen, Carlsbad, CA), and another solution containing 
lipofectamine transfection reagent also diluted with Opti-MEM medium. These two 
mixtures were combined together at room temperature with gentle vortex and incubated 
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for 20 min followed by addition of 10 ml corresponding medium for the treatment groups. 
The mixture was then overlaid onto the 60% confluent NHBE cells. After 48 h, cells were 
harvested for cell cycle and western blot analyses. 
 
Statistical Analysis -- Each experiment was repeated at least three times. Data were 
expressed as mean ± SEM. Statistical comparisons were carried out by one-way analysis 
of variance (ANOVA). Means were examined by the Least Significant Difference post 

















Zinc supplementation markedly reduced cell growth in normal human bronchial 
cells 
In ZD, ZA and ZS cells, cell growth as measured by DNA content per plate, was 
found to be reduced to 83%, 79%, and 67%, respectively, of the ZN cells (Fig.3.1A). The 
culture of cells in zinc depleted medium resulted in significant 18% reduction of cellular 
zinc as compared to control ZN cells (Fig.3.1B). Moreover, cellular zinc level in ZA and 
ZS cells was 150% and 300% of that of ZN control cells, respectively.  Thus cell growth 
as reduced both by the low-zinc and high-zinc status, particularly in ZS cells. w
Furthermore, a dose-dependent elevation in cellular zinc content was observed as the zinc 
concentration in the media was increased. 
 
Gadd45 mRNA abundance was up-regulated in ZS NHBE cells 
Gadd45 mRNA abundance was up-regulated in ZA and ZS NHBE cells to 149±11% 
and 185±5%, respectively, of ZN control cells (100±1%) (Fig.3.2). Although the mRNA 
abundance in ZD cells appeared to be lower than ZN cells, the difference was not 
significant. Thus, in ZA and ZS cells, the marked elevations in Gadd45 mRNA levels 
were associated with increases in cellular zinc levels and reduction in cell growth. 
 
Gadd45 protein level was markedly elevated in ZS NHBE cells 
In ZS cells, western blot analysis indicated an about 5-fold increase in cytoplamic 
and a 4-fold increase in nuclear Gadd45 proteins when compared with the ZN cells 
(Fig.3.3). The cytoplasmic and nuclear Gadd45 protein levels were increased 1.4-fold and 
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1.6-fold, respectively, in ZD cells; as well as 2.2-fold and 1.3-fold, respectively, in ZA 
cells, as compared to ZN control cells. These findings indicated that the magnitude of 
increases in Gadd45 protein among the treatment groups was higher than the increases in 
RNA levels, especially for the ZS group. Thus, there may be additional 
 
inc supplementation delayed G2/M cell cycle progression in NHBE cells 
To uncover the mechanism responsible for the marked cell growth reduction in ZS 
ells, we next examined the cell cycle progression by flow cytometry.  A marked delay 
 G2/M cell cycle progression was observed in ZS NHBE cells (24.39±0.53%) when 
ompared to ZN cells (13.15±0.12%) (Fig.3.4). The delay was smaller in magnitude in 
A cells, with 15.59±0.20% of cells in G2/M (Fig.3.4). In contrast, no change was 
bserved in ZD cells, with 12.98±0.60% cells in G2/M, when compared to ZN cells 
ig.3.4). 
 
RNA mediated gene silencing knocked down Gadd45 protein expression 
The approach of siRNA-mediated gene silencing of Gadd45 was used to establish 
hether the knock down of the marked elevation of Gadd45 in ZS cells would normalize 
e delay in G2/M cell cycle progression. After Gadd45 siRNA tranfection, the Gadd45 
protein levels were knocked down to similar levels in all Gadd45 siRNA transfected zinc 
m
posttranscriptional regulation involved in the enhancement of the protein stability of 
Gadd45.  Because the depression of cell growth induced by an upregulation of Gadd45 
protein is well established, the marked elevation in Gadd45 protein in ZS cells may 












treatments, ZD-Gad (56±14%), ZN-Gad (44±10%) and ZS-Gad (53±8%), as compared to 
siRN
siRNA transfection (Fig.3.6). Importantly, the knocked down of Gadd45, resulted in a 
siRNA mediated suppression of Gadd45 depressed the enhanced phosphorylation of 
p53 at position ser 15 and phosphorylation of p38 in ZS NHBE cells 
Phosphorylated p53 (ser 15) (Fig.3.7) and phosphorylated p38 (Fig.3.8) protein 
levels in ZS cells were induced to around 2-fold and 2.5-fold, respectively, higher than 
ZN cells. Interestingly, after the suppression of Gadd45 mediated by siRNA, these two 
 
 
ZN-C controls (100±9%) (Fig. 3.5).  
 
A mediated Gadd45 knocked down abrogated the blockage in G2/M cell cycle 
progression and triggered apoptosis in ZS NHBE cells 
The blockage in G2/M cell cycle progression was partially abrogated in ZS-Gad 
group. Similarly, ZD-Gad and ZN-Gad showed the same amount of cells in G2/M after 
mild form of apoptosis which was similar among the ZD-Gad, ZN-Gad and ZS-Gad 
treatment groups (Fig.3.6). 
 
induced phosphorylated proteins were decreased to around the same level of ZN control 
cells in all siRNA (ZD-Gad, ZN-Gad, ZS-Gad) treatment groups. These findings suggest 































Zinc supplementation reduced cell growth in NHBE cells. 






































in zinc-deficient (ZD, <0.4 µM zinc), zinc-normal (ZN, 4.0 µM zinc), zinc-ade
µM zinc), and zinc-supplemented (ZS, 32.0 µM zinc) media for one passage. DNA 











 and ZS) for one passage. Cellular zinc was measured by flame atomic absorption 
spectrophotometry. Values are means ± SEM from three experiments. Means with 



























Fig. 3.1B. Cellular zinc level in NHBE cells. 
































































Fig. 3.2. Gadd45 mRNA abundance was up-regulated in ZS NHBE cells. 
ells were cultured in ZD (<0.4 µM zinc), ZN (4.0 µM zinc), ZA (16.0 µM zinc), and ZS 
2.0 µM zinc) media. Cells were cultured for 1 passage in BEGM with zinc added as a 
pplement to the ZD medium. Gadd45 mRNA level was measured by RNase Protection 
ssay (RPA). RNase protection products were separated on a polyacrylamide gel and 





quantitated by laser densitometry. GAPDH was used as an internal refer
are expressed as a percentage of ZN controls. Representative samples from each 
treatment group are shown below the bar-graph. Values are means ± SEM from three 
experiments. Different letters indicate significantly different means, p < 0.05. Treatments 













ig. 3.3A. Relative cytoplasmic Gadd45 protein levels in NHBE cells.  
ells were cultured in ZD (<0.4 µM zinc), ZN (4.0 µM zinc), ZA (16.0 µM zinc), and ZS 
2.0 µM zinc) media. Cells were cultured for 1 passage in BEGM with zinc added as a 
pplement to the ZD medium. Nuclear and cytoplasmic protein extracts were separated 
n 10% polyacrylamide-SDS gels, transferred onto nitrocellulose membranes, and 
cubated with anti-Gadd45 antibody. Cytoplasmic samples were probed with antibodies 
graphy was visualized using enhanced 














































against Actin for normalization. Autoradio
chemiluminescence and quantitated by densitometry. Values are expressed as a 
percentage of ZN controls. Representative samples, from each treatment group, are 
shown below the bar graph. Values are means ± SEM from 3 separated experiments. 


























ig. 3.3B. Relative nuclear Gadd45 protein levels in NHBE cells.  
ells were cultured in ZD (<0.4 µM zinc), ZN (4.0 µM zinc), ZA (16.0 µM zinc), and ZS 
















(32.0 µM zinc) media. Cells were cultured for 1 passage in BEGM with zinc
supplement to the ZD medium. Nuclear and cytoplasmic protein extracts were separated 
on 10% polyacrylamide-SDS gels, transferred onto nitrocellulose membranes, and 
incubated with anti-Gadd45 antibody. Nuclear samples were probed with antibodies 
against Histone H1 for normalization. Autoradiography was visualized using enhanced 
chemiluminescence and quantitated by densitometry. Values are expressed as a 
percentage of ZN controls. Representative samples, from each treatment group, are 
shown below the bar graph. Values are means ± SEM from 3 separated experiments. 


















Fig. 3.4. Zinc supplementation blocked G2/M progression in NHBE cells. 
Cell cycle analysis of NHBE cells was assayed by flow cytometry using a FACScalibur 
cytometer. Cells were cultured in ZD, ZN, ZA, and ZS media for one passage. Washed 
cells were fixed in ethanol and stained with propidium iodide for DNA content. Flow 
cytometric data files were collected and analyzed using the CELLQuest program. Cell 
cycle distribution percentages of stained nuclei were calculated using Modfit LT software. 
The calibration standard LinearFlow Green and the DNA QC particle kit were used for 
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Fig. 3.5. siRNA mediated gene silencing knocked down Gadd45 protein expression  
Nuclear Gadd45 protein levels are presented as percentage of ZN-C (control in ZN 
group). NHBE cells were transiently transfected with either siRNA targeting Gadd45 
(Gad) or Luciferase (Luc) in the treatment groups (ZD-Gad, ZN-Gad, ZS-Gad, ZD-Luc, 
ZN-Luc and ZS-Luc). Control groups (ZD-C, ZN-C and ZS-C) were transfected with 
lipofectamine only (vehicle). Nuclear Gadd45 protein levels were knocked down by 
siRNA targeting Gadd45 in ZD-Gad, ZN-Gad and ZS-Gad treatment groups. 
Representative samples, from each treatment group, are shown below the bar graph. 
Values are means ± SEM from 3 separated experiments. Different letters indicate 

































































-Gad, ZS-Gad, ZD-Luc, ZN-Luc and ZS-Luc. 
Cells were harvested and washed, followed by fixation in ethanol, and stained with 
propidium iodide for DNA content. Flow cytometric data files were collected and 
analyzed using the CELLQuest program. Cell cycle distribution percentages of stained 









Fig. 3.6. siRNA mediated Gadd45 knocked down released the delay in G2/M cell 
cycle progression in ZS NHBE cells 
Cell cycle analysis was performed after siRNA transfection. NHBE cells were transient 
transfected with either siRNA targeting Gadd45 (Gad) or Luciferase (Luc) in the 
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 knocked down of 
Gadd45 by siRNA 
NHBE cells were transiently transfected with either siRNA targeting Gadd45 (Gad) or 
Luciferase (Luc) in the treatment groups (ZD-Gad, ZN-Gad, ZS-Gad, ZD-Luc, ZN-Luc 
and ZS-Luc). Control groups (ZD-C, ZN-C and ZS-C) were transfected with 
lipofectamine only (vehicle). After 48 hours, cells were lysed and analyzed. Total cell 
extracts were separated on 10% polyacrylamide-SDS gels, transferred onto nitrocellulose 
membranes, and probed with anti-phospho-p53 (ser15) antibody. Autoradiography was 
visualized using enhanced chemiluminescence and quantitated by densitometry. Values 
are expressed as a percentage of ZN controls. Representative samples, from each 
treatment group, are shown below the bar graph. Different letters indicate significantly 











































































ig. 3.8. Phospho-p38 protein level was affected after knocked down of Gadd45 by 
RNA 
HBE cells were transiently transfected with either siRNA targeting Gadd45 (Gad) or 
uciferase (Luc) in the treatment groups (ZD-Gad, ZN-Gad, ZS-Gad, ZD-Luc, ZN-Luc 
and ZS-Luc). Control groups (ZD-C, ZN-C and ZS-C) were transfected with 
lipofectamine only (vehicle). After 48 hours, cells were lysed and analyzed. Total cell 
extracts were separated on 10% polyacrylamide-SDS gels, transferred onto nitrocellulose 
membranes, and probed with anti-phospho-p38 antibody. Autoradiography was visualized 
using enhanced chemiluminescence and quantitated by densitometry. Values are 
expressed as a percentage of ZN controls. Representative samples, from each treatment 
group, are shown below the bar graph. Values are means ± SEM from 3 separated 

















































f zinc supplem gulation of Gadd45 
xpression. The administration of small interference RNA targeting Gadd45 abrogated 
e G2/M blockage in zinc supplemented NHBE cells. The silencing of Gadd45 also 
ppressed the phosphorylated-p53 (ser 15) and phosphorylated-p38 levels, which 
dicate that Gadd45 may contribute to the enhanced phosphorylation of p53 and p38 in 
sponse to the stress induced by zinc supplementation in NHBE cells. 
 
inc supplementation inhibits normal human bronchial cells proliferation 
Our studies were designed to investigate the influence of zinc depletion and 
pplementation on the cell signaling and cell cycle regulation by Gadd45 in normal 
human bronchial epithelial cells (NHBE). In zinc supplemented NHBE cells, cellular zinc 
was threefold higher than that of ZN control group (Fig.3.1B), and cell growth as 
measured by cell number was decreased to 60% of ZN (Fig.3.1A). Our study is the first 
to demonstrate that zinc supplementation, within the physiological range, is cytotoxic and 
reduces the growth of NHBE in primary culture. Thus, high physiologic level of zinc also 
imposes adverse effect in normal cells. Controversy towards the efficacy of zinc 
supplementation in the prevention of cancer growth has been reported. Several studies 
have indicated that high cellular zinc levels inhibit cancer cell growth (Bataineh et al., 
2002; Feng et al., 2000; Uzzo et al., 2002). Moreover, studies also reported that treatment 
with high level of zinc not only inhibited proliferation cancer cells but also induced G2/M 
arrest (Jaiswal et al., 2004; Liang et al., 1999). However, epidemiological study has 
In this report, we provide evidence that G2/M blockage found in physiological range 










ported an increas  high level of zinc 
pplement (Leitzma entation can inhibit 
ancer cell pr ion, the cytotoxic effect of zinc (90 and 900 μmol/L) resulting in the 
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Upregulation of Gadd45 is associated with cell growth suppression in ZS NHBE 
cells 
anied by marked 
ain regulator in 
cell growth inhibition in zinc supplemented NHBE cells. This hypothesis is supported by 
numerous findings regarding the function of Gadd45 reported by other research group. 
Several findings have established that over-expression of Gadd45, by transient 
transfection and tet-off inducible system, substantially inhibits cell growth in multiple 
tumor lines (Zhan et al., 1994; Jin et al., 2002). In addition, Gadd45 has been established 
to be downstream of p53-dependent pathway in cells harboring functional p53 or 
null-p53. To determine whether Gadd45 is the single regulator of p53-dependent pathway 
in response to cellular stress, experiment is in progress, and p21WAF/CIP1 is the candidate 
gene to be studied. Although Gadd45 reveals a similar growth suppressive property as 
p21WAF/CIP1, it does not utilize Rb-related pathways and may act differently to exert its 
growth-suppressive function.   
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Our results demonstrate that cell growth suppression was accomp
induction of Gadd45 expression, suggesting that Gadd45 may be the m
G2/M blockage was found in ZS NHBE cells 
cell growth. The 
underlying mechanism by which Gadd45 blocks the G2/M cell cycle progression needs to 
1, which 
decre
In our studies, cell cycle analysis by flow cytometry showed there was G2/M 
blockage in ZS cells (Fig. 3.4). In ZS cells, G2/M blockage was accompanied by three to 
fivefold induction of nuclear and cytoplasmic Gadd45 proteins levels, respectively (Fig 
3.3A & 3.3B), and by two-fold increase in mRNA expression (Fig.3.2) as compared to 
ZN control cells.  These results suggest that zinc supplementation may cause cellular 
stress which induces Gadd45 expression. With the increase in Gadd45 expression in ZS 
cells, G2/M blockage occurs to delay the transition and hinder 
be further investigated. This probably is due to the binding of Gadd45 to CDK
ases CDK1 kinase activity, and hinders the cell progression from G2 to M. High 
dosage of zinc has been reported to induce DNA fragmentation in human cells, implying 
that DNA damage may occur in high zinc supplementation. The molecular mechanism by 
which stress signals arrest at G2/M checkpoint is still not fully established. The cell cycle 
control system is based on the CDK and the cyclins. Cyclin B1 undergoes a cycle of 
synthesis and degradation with each division cycle, is capable of binding to CDK1. This 
dimer forms the M phase-promoting factor (MPF) during G2 and is required for entry 
into mitosis. Gadd45 has been shown to bind Cdk1 and inhibit its activity or alter the 
subcellular level of Cyclin B1 in human cells when exposed to stresses like ionizing 
radiation or ultra violet radiation (Jin et al., 2002; Zhan et al., 1999; Jin et al., 2000). 
Gadd45 induces G2/M arrest through p53-dependent and independent pathways by 
decreasing Cdk1 kinase activity and changing subcellular Cyclin B1 levels in many cell 
types when exposed to stresses (Wang et al., 1999; Mullan et al., 2001; Maeda et al., 
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2002; Jiang et al., 2003; Mak et al., 2004).  The effect of Gadd45 on the G2/M transition 
may be due to its ability to reduces complex formation of Cyclin B1and CDK1 and 
inhibit the activity of CDK1/Cyclin B1 in vitro (Zhan et al., 1999; Jin et al., 2000).  In 
the present study, no G1 arrest was observed in our study. This is consistent with data 
from another study which showed that Gadd45 did not efficiently inhibit CDK2/Cyclin E 
nor caused G1 arrest when microinjected (Zhan et al., 1999). However, observed G2/M 
 Gadd45 may cooperate with other downstream targets of p53, such as p21, whose 
cons
mented cells. After the knock down of Gadd45, a small 
but similar extend of apoptosis was observed among all zinc treatment groups in NHBE 
cells. This is because the suppression of Gadd45 can no longer protect cells from 
blockage may require p53 if Gadd45 acts directly on CDK1/Cyclin B1. One explanation 
is that
titutive expression is lost upon deletion of p53 (Tang et al., 1998). 
 
The upregulation of Gadd45 accounts for the G2/M blockage in ZS NHBE cells 
To show the involvement of Gadd45 in G2/M cell cycle regulation in zinc 
supplemented NHBE cells, we initiated the small interfering RNA targeting Gadd45 
experiment to knock down Gadd45.  The success of knocking down Gadd45 was 
confirmed by the marked reduction in Gadd45 protein level (Fig.3.5). Gadd45 protein 
was knocked down to 40-50% of ZN control group (ZN-C). Consistent with reports from 
other research groups, which studied the effect of knocking out Gadd45, cell cycle 
analysis of NHBE cells by flow cytometry indicated a decrease in G2/M blockage in ZS 
cells after targeting Gadd45 siRNA (ZS-Gad) than in ZS control groups (ZS-C & ZS-Luc; 
Fig.3.6 & Table 2). Thus, the up-regulated Gadd45 expression may partially account for 
the G2/M blockage in zinc supple
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apoptosis under the toxic status induced by zinc supplementation.  The reason for the 
abrogated G2/M blockage not normalizing to level of ZN (ZN-C) cells may be due to 
another signaling pathway independent of Gadd45 that regulates G2/M transition, which 
may include p38. This project provides evidence that Gadd45 plays a direct role in the 
G2/M cell cycle checkpoint in zinc supplemented NHBE cells. In addition the findings 
are consistent with other studies which reported the correlations of Gadd45 upregulation 
with G2/M arrest in human fibroblasts (Wang et al., 1999; Maeda et al., 2002; Smith et al., 
1996).  
 
Possible pathways regulate Gadd45 in G2/M blockage in ZS NHBE cells 
Gadd45 was shown to be a direct target gene of p53 tumor suppressor gene, and 
plays a vital role in cell cycle progression. Gadd45 can be regulated either by 
p53-dependent or –independent pathway in response to stress.  In this study, the p53 
mRNA and protein expressions exhibited similar increases in ZS NHBE cells (data not 
shown). Moreover, the silencing of Gadd45 suppressed the phosphorylation of p53 at 
position serine 15 which is required for activation of p53, suggesting that Gadd45 can 
behave as an upstream activator of p53 phosphorylation process through another 
mechanism. Our findings on the relationship of Gadd45 and p53 indicated that the 
upregulation of Gadd45 enhanced the phosphorylation of p53. Similarly, other studies 
have shown that upregulation of Gadd45 is capable of enhancing p53 protein level 
through a positive feedback loop by binding to MTK1 and activating p38 indirectly (Jin 
et al., 2003; Takekawa et al, 1998). Moreover, studies have established that Gadd45 can 
bind with PCNA (Ph-tani-Fujita et al., 1998; Kearsey et al., 1995; Smith et al., 1994) and 
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p21WAF/CIP1 (Vairapandi et al., 1996) which are downstream regulators of p53. 
Furthermore, chromatin immunoprecipitation studies have shown that p53 preferentially 
binds to the responsive element in the promoters of p21 and GADD45 but not to 
promoters of other target genes that recruited p53 following DNA damage (Jackson et al., 
2006). Therefore, the observed enhanced Gadd45 expression possibly may act in a 
p53-dependent pathway in the G2/M blockage in the ZS NHBE cells. 
Another possible regulatory pathway responsible for the upregulation of Gadd45 in 
ZS NHBE cells is the interaction of Gadd45 protein with the activated p38 MAPK 
directly or indirectly. Indirectly, Gadd45 can bind to N-terminal of MTK1 and disrupt 
MTK1 itself N-C interaction. This Gadd45-binding induces MTK1 N-C dissociation, 
 p38 
(Miy
dimerization, and autophosphorylation and leads to activation of MAPK, including
ake et al., 2007). Directly, there is on p38 one interacting domain in the region of 
amino acids 71 to 96 in Gadd45. And this region is required to activate p38 in the 
presence of H-ras oncogene (Bulavin et al., 2003). In our study, we demonstrated that 
silencing Gadd45 suppressed p38 phosphorylation, suggesting that the activation of p38 
is mediated through Gadd45 protein. The Gadd45 protein may directly bind to p38 
upstream regulator, such as MTK1 and trigger the phosphorylation of p38 in ZS NHBE 
cells. The activated p38 then binds to downstream regulator, p53, and activates its 
function, and consequently arrests the NHBE cells in G2/M. Apart from interacting with 
Gadd45 in stress induced G2/M arrest, p38 also acts independently of p53 pathway by 
shuttling phosphatase CDC25B from nucleus to cytoplasm and recruited 14-3-3 to bind to 
CDC25B (Bulavin et al., 2001). CDC25B is required to activate CDK1 by removing two 
phosphate groups and it is required for entry into mitosis. 
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In summary, the present results presented above provide novel findings that zinc 
supplementation, in a physiologically relevant system, exerted adverse effect in normal 
cells, markedly elevated Gadd45 expression, inhibited G2/M progression, and enhanced 
phosphorylation of p53 (ser 15) and p38 in NHBE cells, and the related mechanism 
responsible for the cell cycle arrest in normal human cells.  A better understanding of 
the mechanisms involved in the protection of normal cells from zinc cytotoxicity is 
essential for the identification of potential targets, such as Gadd45, p53 and p38, and may 
contribute to the development of future therapeutic approaches for the treatment of 




Up-regulates Gadd45 expressions and promoter activity, 
impairs CDK1/Cyclin B1 complex formation and delays G2/M 




Zinc supplementation has been established to be beneficial in the human body 
including enhanced immune system and normalization of stunted growth. However, zinc 
supplementation in physiological range was found to be cytotoxic in cell culture system 
in this study. p53 plays a central role in the modulation of cell signal transduction in 
response to the stress from DNA damage, hyporexia and oncogene activation. In this 
study, we demonstrated for the first time that an elevated zinc status, created by culturing 
cells at optimal plasma zinc concentration attainable by oral zinc supplementation, is 
cytotoxic for normal human bronchial epithelial (NHBE) cells. Cells were cultured for 
one passage in different concentrations of zinc: <0.4 μM (ZD) as zinc deficient; 4 μM as 
normal zinc level in culture medium; 16 μM (ZA) as normal human plasma zinc level; 
and 32 μM (ZS) as the high end of plasma zinc attainable by oral supplementation. 
Inhibition of cell growth, up-regulation of p53 mRNA and protein expressions, and 
blockage of G2/M cell cycle progression were observed in ZS cells. The dependency on 
p53 in the modulation of Gadd45 expression was established by applying p53 protein 
inhibitor, Pifithrin, to inhibit p53 transactivation activity. The elevated Gadd45 protein 
level and Gadd45 promoter activity caused by zinc supplementation were normalized by 
Pifithrin treatment to the level of ZN control cells, suggesting that the ZS induced p53 is 
responsible for the enhanced transactivation of Gadd45 promoter.  
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Furthermore, the reduction in the level of CDK1/Cyclin B1 complex and the G2/M 
blockage in ZS cells was normalized almost to that of ZN cells by Pifithrin treatment, 




concentration of zinc in the air ma alth risk (Merchant et al., 2001). 
Zinc toxicity can cause acute respiratory tract inflammation together with bronchial 
hyper-responsiveness. Studies have shown that workers in mining industries have 
increased polymorpho-nuclear leukocytes and incidence of pulmonary inflammation 
(Blanc et al., 1991). In view of the prevalence and clinical significance of zinc deficiency 
in human populations, as well as extensive use of zinc supplementation in animal 
production and to a lesser extend in human populations, we have initiated studies 
designed to examine the influence of zinc status on the expression of tumor suppressor 
genes, p53, and the growth arrest and DNA damage-induced gene (Gadd) Gadd45, in 
Normal Human Bronchial Epithelial (NHBE) cells. NHBE cells have been selected for 
this study because they are more representative of the cell population during lung tissue 
. 
Bronchial epithelial cells are the physical barrier that separate airway connec
tissue and smooth muscle from the airway luminal contents. Exposure to high 
y cause significant he
transformation and are considered to be progenitor cells for human bronchial cancer
Tumor suppressor gene p53 is the most frequently mutated gene in cancer 
(Vogelstein and Kinzler, 1992) and has been implicated in maintaining genomic stability 
by controlling cell cycle checkpoints and apoptosis following genotoxic stress (Kastan et 
al., 1992; Zhan et al., 1994b; Miyashita and Reed, 1995; Waldman et al., 1995; White, 
1996; Levine, 1997). Stresses including UV radiation, alkylating agents and ionizing 
radiation damage DNA and activated protein, such as p53, which is stabilized and 
activated as a transcription factor (Kastan et al., 1991; Zhan et al., 1993). Activated p53 
transactivates its downstream genes, including Gadd45, p21 and Bax (El-Deiry et al. 
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1993
ript that was rapidly induced in 
response to UV radiation (Fornace et al., 1989). Gadd45 is ubiquitously expressed as a 
21kD acidic protein in response to genotoxic agents, and is involved in many biological 
processes related to the maintenance of genomic stability and apoptosis. Gadd45 has been 
implicated to interact with PCNA, p21, CDK1 and MTK1 (Smith et al., 1994; Kearsey et 
al., 1995; Zhao et al., 2000; Takekawa and Saito, 1998). Gadd45 also has been 
established to regulate G2/M arrest in response to genotoxic stress and maintainance of 
genomic stability. Regulation of Gadd45 induction after DNA damage is complex and 
may involve both p53-dependent and -independent signaling pathways. Gadd45 induction 
by IR has been reported to be strictly dependent on normal cellular p53 function. 
However, Gadd45 induction by UV and MMS does not require p53 although p53 may 
contribute to the non-IR response of Gadd45 (Kastan et al., 1992; Zhan et al., 1996). 
The objectives of our study were to determine whether the increased Gadd45 
expression with the blockage of G2/M in zinc supplemented NHBE cells is 
p53-dependent or p53-independent, to decipher the precise molecular mechanisms 
responsible for the regulation of Gadd45 expression by p53, and to elucidate Gadd45 
functions in growth arrest and cell cycle progression in NHBE cells.  This study 
provided evidence for the first time to show that the upregulation of Gadd45 is dependent 
on p53 in the delay in G2/M progression, by the application of p53 inhibitor, Pifithrin, 
which inhibited the transactivation of p53 function, in NHBE cells culture at optimal zinc 
concentration previously established to be attainable in the plasma by oral 
, Kastan et al., 1992; Zhan et al., 1994a, 1993). Subsequently, cell cycle arrest or 
apoptosis will prevent the cells from passing damaged DNA to mitotic cells. 




4.3. MATERIALS AND METHODS 
Cell Culture and treatment --NHBE cells were purchased from Cambrex Bio Science 
(Walkersville, MD). Cells were plated at 3,500 cells/cm2 in tissue culture dishes 
containing bronchial epithelial cell growth medium (BEGM), supplemented with 0.5 
µg/ml epinephrine, 10 µg/ml transferrin, 5 µg/ml insulin, 0.1 ng/ml retinoic acid, 52 
µg/ml bovine pituitary extract, 0.5 µg/ml hydrocortisone, 0.5 pg/ml human recombinant 
epidermal growth factor, and 6.5 ng/ml triiodothyronine (as growth supplements) without 
antibiotics, and cultured at 37°C in a 5% CO2 incubator. The cells were grown to 80% 
confluence for 6 days, and subcultured using trypsin-EDTA at a ratio of 1: 8 at passage 3 
for experimental zinc treatment. 
A zinc-free BEGM baseline medium, in which Cambrex omitted the addition of 
ZnSO4, was used as the zinc-depleted media.  This media consisted of Bronchial 
Epithelial Basal Media (BEBM) supplemented with growth components, and contained 
resid
4.  
ual amounts of zinc (<0.4 μM), as detected by flame atomic absorption 
spectrophotometry.  The zinc-free basal medium of <0.4 μM was used as the 
zinc-depleted medium (ZD). For the other four treatment groups, zinc was added to the 
media in the form of ZnSO4 so that the only difference between these media was the zinc 
concentration.  For the zinc-normal medium (ZN) contained 4 μM of ZnSO4, the 
zinc-adequate medium (ZA) contained 16 μM of ZnSO4, and the zinc-supplemented 
medium (ZS) contained 32 μM ZnSO The ZN medium was used as a comparison to 
standard culture media and was used as the control group for experiments.  The ZA 
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treatment was used as a representative of human plasma zinc levels, and the ZS group 





r NHBE cells were subcultured and assigned into one of the four corresponding 
groups, the cells were cultured overnight in ZN media before changing to their respective 
medium.  Cells were then cultured in ZD, ZN, ZA and ZS for 6 days. Pifithrin (PFT) 
was purchased from Sigma-Aldrich (Sigma-Aldrich, St. Louise, MO), Chemicals were 
used as stock solutions in dimethylsulfoxide. PFT was administrated into the cells in the 
working concentration of 2 μM for 48 h. 
 
RNase Protection Assay -- Total RNA was isolated from NHBE cells using the 
RNAqueous Kit (Qiagen, Valencia, CA), according to manufacturer’s instruction and the 
integrity of the RNA was verified by electrophoresis and quantified by spectrophotometry. 
The mRNA abundance of human genes including, PARP, NF-κB, TNF-β, p53, Gadd45, 
p38, p21, Brca1, PCNA, MDM2, were measured by non-radioactive RNase Protec
y (Pharmingen, San Diego, CA). The human GAPDH probe was also included in the 
multi-probe and was used as house-keeping gene for normalization.  Labeled riboprobes 
were synthesized using the Non-Radioactive In Vitro Transcription kit with T7 RNA 
polymerase (Pharmingen, San Diego, CA), and Biotin-dUTP (Roche, Alameda, CA). 
RNase Protection Assay (RPA) was performed using the Pharmingen RPA kit. Each 
sample contained 10 μg of total RNA from NHBE cells, and 2 μg of the multi-riboprobe. 
The RNA and labeled probes were co-precipitated with ammonium acetate and ethanol, 
and resuspended in hybridization buffer at 56oC for 16 h. The RNase digestion was 
performed at 30oC for 45 min, followed by inactivation with proteinase K cocktail, and 
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subsequent precipitation. Protected fragments were separated by Tris-Urea 
Polyacrylamide Gel Electrophoresis (PAGE) using pre-casting gel from BioRad 
ocessed without RNase digestion, only 
ann (Zerbini et al., 2004). The promoter region was 
isola
NHBE cells, in complete medium, were seeded at a density of 2 × 105 cells/well in 
24-well plates and cultured for 4 days in complete medium containing 0, 4.0, or 32.0 µM 
zinc. Just before transfection, the medium was removed. Transfections were performed in 
(Hercules, CA). Control samples were pr
full-length probes were applied. No protected bands appeared in controls, in which yeast 
RNA replaced NHBE RNA indicating that digestion was complete. The PAGE gel 
resolved protected probes were transferred to nylon membrane and subjected to UV 
crosslinking. The biotin-labeled protected cDNA transferred to the membrane were 
detected by chemiluminescent signal and visualized by X-ray film exposure. 
 
Gadd45 Promoter Activity Assay 
Preparation of Gadd45-Luciferase The Gadd45 promoter construct was a kind gift 
provided by Dr. Towia Liberm
ted and inserted into the plasmid pGL3-basic (Promega, Madison, WI) to generate 
construct pGL3-Gadd45-Luci plasmid. The plasmid was transfected into E. coli DH5α 
competent cells (Invitrogen, Carlsbad, CA) by standard protocol for transformation. The 
plasmid was prepared by using Wizard PureFection Plasmid DNA purification system 
from Promega (Madison,WN).  
 
Transient Transfection and Luciferase Assay – NHBE cells were transfected by using 
Tfx-20 reagent according to the protocol provided by the manufacturer (Promega). 
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triplicate with 500 ng of the plasmid DNA containing the wild-type Gadd45 promoter 
luciferase reporter construct and 10 ng of an internal control plasmid, pRL-SV40 
(Promega). One hour after transfection, the transfection medium was changed to their 
respective media and cultured for 2 more days. Luciferase activity was measured in the 
Luminometer TD-20/20 (Turner Designs, Sunnyvale, CA) by using the Dual-Luciferase 
reporter Kit according to recommendations by the manufacturer (Promega). Changes in 
firefly luciferase activity was calculated and plotted after normalization with changes in 




Cell Cycle Analysis -- DNA contents of cells were assayed by fluorescence-activated cell 
sorting (FACS). NHBE cells were cultured in ZD, ZN, ZA, and ZS media for one passage, 
trypsinized, washed in PBS (Ca2+, Mg2+ free), and fixed in 70% cold ethanol. Cells were 
stored at 4°C. For staining, cells were collected by centrifugation, and pellets were 
suspended in 1.0 ml propidium iodide staining solution (50 mg per ml propidium iodide, 
100 U per ml RNase in PBS), and incubated at room temperature for 1 h. Staining was 
quantitated with a FACSCalibur cytometer (Becton Dickinson, San Jose, CA). The cell 
numbers were acquired with CELLQuestPro software program (Becton Dickinson, San 
Jose, CA). Cell cycle distribution percentages of stained nuclei were calculated by u
fit LT software (Verity Software House, Topsham, ME). The calibration standard 
LinearFlow Green and the DNA QC Particle kit, for verification of instrument 
performance, were purchased from Molecular Probes (Eugene, OR) and Becton 
Dickinson, respectively.  
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Nuclear and Cytoplasmic Extract Preparation -- The NE-PER Nuclear and 
Cytoplasmic Extraction Reagents and the Halt Protease Inhibitor Cocktail Kits (Pierce 
Biotechnology, Rockford, IL) were used for nuclear and cytoplasmic extracts preparation 
according to the manufacturer’s instructions, which are based on the method of Smirnova 
et al. (2000). Nuclear and cytoplasmic extracts were then stored in aliquots at -80°C. 
Protein concentrations were determined by using the BCA Protein Assay Reagent kit 
(Pierce, Rockford, IL). Contaminations of nuclear extracts by cytoplasmic proteins or 
contaminations of cytoplasmic extracts by nuclear proteins, detected by Western blot 
nalysis of Hsp90 or Oct-1, respectively, were routinely found to be less than 5% in our 
 137mM NaCl, 2.7mM KCL, and 0.1% Tween 20) for 




Western Blot Analysis -- Nuclear and cytoplasmic protein concentrations were 
determined by using the BCA kit (Pierce). Forty µg of protein were resolved on a 10% 
SDS-polyacrylamide gel electrophoresis and transferred to Hybond ECL nitrocellulose 
membrane (Amersham Pharmacia Biotech, Germany) by using a mini-transfer system 
(Bio-Rad, Hercules, CA).  Membranes were blocked with 5% nonfat dry milk in PBS-T 
(10mM phosphate buffer pH7.3,
1
Cruz Biotechnology (Santa Cruz, CA), in PBS-T containing 5% nonfat milk at 4°C 
overnight. Membrane was then washed three times with PBS-T and blotted with a 
secondary antibody conjugated with horseradish peroxidase (Santa Cruz, Santa Cruz, CA) 
at room temperature for 1 h, followed by three washes in PBS-T. The protein was 
visualized by using the SuperSignal West Pico Chemiluminescent Substrate (Pierce, 
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Rockford, IL). Anti-Gadd45, anti-p53, anti-Cyclin B1, anti-actin and anti-histone H1 
were purchased from Santa Cruz Biotechnology (Santa Cruz, Santa Cruz, CA). 
 
Immunoprecipitation of CDK1/CyclinB1 – Seventy percentage confluency of cells 
were harvested, and washed with 10 ml of PBS. Cells were then washed and resuspended 
in 1 ml of cold lysis Buffer containing 1X Protease Inhibitor Cocktail (Pierce, Rockford, 
IL). Cells were then placed on ice for 30 min and centrifuged at 10,000 x g for 15 min at 
4oC. The supernatant was collected in new microcentrifuge tube.  Protein concentration 
 the whole cell lysates were determined by BicinChoninic Acid (BCA) reagent kit in
(Pierce).  Five hundred μg of proteins from whole cell lysate were added to 50 μl of 
Protein G (Santa Cruz Biotechnology), washed with cold lysis buffer, and incubated on 
ice for 1 h. The complex was then centrifuged at 10,000 x g for 10 min at 4°C. Ten μg of 
Cyclin B1 antibody or rabbit polyclonal antibody (Santa Cruz Biotechnology) were 
added to the precleared lysate and incubated for 1 h. Protein A/G PLUS agarose (Santa 
Cruz Biotechnology) was added and incubated at 4°C for overnight on a rocking platform. 
The immunocomplexes were centrifuged at 10,000 x g for 30 seconds at 4°C and washed 
five times with 500 μl of lysis buffer. The 50 μl of 1X Laemmli sample buffer were added 
to the immunocomplexes as bead pellet. The immunocomplexes were vortexed and 
heated to 95°C for 5 min and spinned at 10,000 x g for 5 min, and loaded onto the 10% 





Statistical Analysis --Each experiment was repeated at least three times. Data were 
expressed as mean ± SEM. Statistical comparisons were carried out by one-way analysis 
of variance (ANOVA). Means were examined by the Least Significant Difference post 





Zinc supplementation markedly reduced cell growth in NHBE cells 
In ZD, ZA and ZS cells, cell growth as measured by cell number per plate, was 
 
dance was up-regulated in ZS NHBE cells 
p53 mRNA abundance was up-regulated in ZA and ZS NHBE cells to 129±2% and 
196±16%, respectively, of ZN control cells (100±5%) (Fig.4.4). The mRNA abundance 
found to be reduced to 79±1.7%, 84±3.9%, and 68±5.0%, respectively, of the ZN cells 
(Fig.4.1). The culture of cells in zinc depleted medium resulted in significant 18% 
reduction of cellular zinc as compared to control ZN cells (Fig.4.2). Moreover, the 
cellular zinc level in ZA and ZS cells was 150% and 300% of that of ZN control cells. 
Thus, cell growth was reduced both by the low-zinc and high-zinc status, particularly in 
ZS cells. Furthermore, a dose-dependent elevation in cellular zinc content was observed 
as the zinc concentration in the media was increased. 
 
Zinc supplementation delayed G2/M cell cycle progression in NHBE cells 
To uncover the mechanism responsible for the marked cell growth reduction in ZS 
cells, we next examined the cell cycle progression by flow cytometry.  A marked delay 
in G2/M cell cycle progression was observed in ZS NHBE cells (24.39±0.53%) when 
compared to ZN cells (13.15±0.12%) (Fig.4.3). The delay was smaller in magnitude in 
ZA cells, with 15.59±0.20% of cells in G2/M (Fig.4.3). In contrast, no change was 





in ZD cells was only 17±4% of the ZN cells. Thus, in ZA and ZS cells, the marked 
elevations in p53 mRNA levels were associated with increases in cellular zinc levels and 
reduction in cell growth. Also, the p53 mRNA level in ZD was associated with decrease 
in cellular zinc levels and reduction in cell growth. 
 
53 protein level was markedly elevated in ZS NHBE cells 
In ZS cells, western blot analysis indicated approximately a 4-fold increase in 
cytoplamic and a 3-fold increase in nuclear p53 protein levels when compared with the 
ZN cells (Fig. 4.5A & 4.B). The cytoplasmic and nuclear p53 protein levels were 
increased 3-fold and 2.4-fold, respectively, in ZD cells; as well as 2.9-fold and 2.8-fold, 
respectively, in ZA cells, as compared to ZN control cells. These findings indicated that 
the magnitude of increases in p53 protein among the treatment groups were higher than 
the increases in mRNA levels, especially for the ZS group. Thus, there may be additional 
posttranscriptional regulation involved in the enhancement of the protein stability of p53.  
Because the depression of cell growth induced by an upregulation of p53 protein is well 
established, the marked elevation in p53 protein in ZS cells may contribute to the 
observed reduction in cell growth. 
 
The blockage in G2/M cell cycle progression was alleviated by Pifithrin treatment in 
ZS NHBE cells 
The blockage in G2/M cell cycle progression was alleviated in the ZS-Pifithrin 
group. Similarly, ZD-Pifithrin and ZN-Pifithrin groups showed the similar amount of 
cells in G2/M after inhibition of p53 transactivation by Pifithrin (Fig.4.6). After 
p
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administration of Pifithrin, the cells in G2/M dropped from 8.91±0.12% to 7.42±0.27% in 
o 8.56±1.04% in 
ZS c
ated cells, ZD-Pifithrin (87±8%), 
ZN-Pifithrin (90±3%) and ZS-Pifithrin (92±2%), as compared to ZN-controls (100±17%) 
rotein levels were reduced to similar levels in all Pifithrin treated cells, 
ZD-Pifithrin (87±8%), ZN-Pifithrin (90±3%) and ZS-Pifithrin (92±2%), as compared to 
ZD cells, 10.76±0.98% to 8.82±1.03% in ZN cells, and 15.03±0.19% t
ells. 
 
Gadd45 protein expression was reduced after Pifithrin treatment 
The approach of suppressing p53 transactivation activity was used to establish 
whether the upregulated of Gadd45 was associated with elevated p53. Our data showed 
that the marked elevation of Gadd45 in ZS cells was reduced after the usage of Pifithrin. 
After inhibition of p53 transactivation activity by Pifithrin, the Gadd45 protein levels 
were reduced to similar levels in all Pifithrin tre
(Fig.4.7).  
 
Gadd45 promoter activity was decreased after Pifithrin treatment 
The approach of suppressing p53 was used to establish whether the upregulated of 
Gadd45 promoter activity was associated with elevated p53. Our data showed that the 
marked elevation of Gadd45 promoter activity in ZS cells was decreased by Pifithrin 
treatment. After the suppression of p53 transactivation with the Pifithrin inhibitor, the 
Gadd45 p




Reduction in CDK1/Cyclin B1 complex level in ZS NHBE cells was normalized by 
p53 transactivation inhibitor Pifithrin treatment 
The formation of CDK1/Cyclin B1 complex in ZS NHBE cells was lower compared 
to ZN control cells (Fig. 4.9): ZS-control (62±4%) and ZS-mock (56±4%), as compared 
with ZN-control (100±17%) (Fig.8). In ZD cells, the CDK1/Cyclin B1 complex showed 




no significant changes, ZD-control (110±6%) and ZD-mock (1
ontrol (100±6%) (Fig.4.9). To examine whether this reduction of the CDK1 and 
Cyclin B1 complex formation was dependent on p53 in ZS NHBE cells, suppression of 
p53 transactivation by inhibitor Pifithrin was performed.  The amount of CDK1/Cyclin 
B1 complex were quantified by immunoprecipitation in all zinc treated groups, and the 
results showed that the depressed CDK1/Cyclin B1 complexes were normalized after 
suppression of p53 transactivation:  ZD-Pifithrin (113±9%), ZN-Pifithrin (129±0%) and 






























































Fig. 4.1. Reduction in cell number in zinc deficient and supplemented cells.  
Cell number per plate in normal human bronchial epithelial (NHBE) cells after cultured 
in zinc-deficient (ZD, <0.4 µM zinc), zinc-normal (ZN, 4.0 µM zinc), zinc-adequate (ZA, 
16.0 µM zinc), and zinc-supplemented (ZS, 32.0 µM zinc) media for one passage. Cell 
number was determined by using hemacytometer. Similar results were obtained from 







ig. 4.2. Cellular zinc level in NHBE cells. 
ellular zinc level in NHBE cells treated with different concentrations of zinc (ZD, ZN, 
A and ZS) for one passage. Cellular zinc was measured by flame atomic absorption 
ectrophotometry. DNA content per plate in NHBE cells was determined by 
iphenylamine method. Values are means ± SEM from three experiments. Means with 
ifferent letters are significantly different (p < 0.05). Similar results were obtained from 






























































    
ig. 4.3. Zinc supplementation blocked G2/M progression in NHBE cells. 
ell cycle analysis of NHBE cells was assayed by flow cytometry using a FACScalibur 
ytometer. Cells were cultured in ZD, ZN, ZA, and ZS media for one passage. Washed 
ells were fixed in ethanol and stained with propidium iodide for DNA content. Flow 
ytometric data files were collected and analyzed using the CELLQuest program. Cell 
cycle distribution percentages of stained nuclei were calculated using Modfit LT software. 
The calibration standard LinearFlow green and the DNA QC particle kit were used for 
verification of instrument performance. Histograms are representative of three 
independent experiments. The proportions of cells in G0/G1, S phase and the G2/M ratios 
are indicated for each treatment group. Similar results were obtained from experiments 
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Fig. 4.4. p53 mRNA abundance was up-regulated in ZS NHBE cells. 
ells were cultured in ZD, ZN, ZA, and ZS media. Cells were cultured for one passage in 
o the ZD medium. p53 mRNA level was 
the same letters indicate no significant 
ifference. Similar results were obtained from experiments with cells from another 
subject. 
C
BEGM with zinc added as a supplement t
measured by RNase Protection Assay (RPA). RNase protection products were separated 
on a polyacrylamide gel and quantitated by laser densitometry. GAPDH was used as an 
internal reference, and values are expressed as a percentage of ZN controls. 
Representative samples from each treatment group are shown below the bar-graph. 
Values are means ± SEM from three experiments. Different letters indicate significantly 













































Fig. 4.5A. p53 cytoplasmic protein level was markedly elevated in ZS NHBE cells. 
Cells were cultured for one passage in BEGM with zinc added as a supplement to the ZD 
medium. Nuclear and cytoplasmic protein extracts were separated on 10% 
polyacrylamide-SDS gels, transferred onto nitrocellulose membranes, and incubated with 
anti-p53 antibody. Cytoplasmic samples were probed with antibodies against Actin for 
normalization. Autoradiography was visualized using enhanced chemiluminescence and 
quantitated by densitometry. Values are expressed as a percentage of ZN controls. 
Representative samples, from each treatment group, are shown below the bar graph. 
Values are means ± SEM from 3 separated experiments. Different letters indicate 
significantly different means, p < 0.05.  Similar results were obtained from experiments 















Fig. 4.5B.  p53 nuclear protein level was markedly elevated in ZS NHBE cells. 
Cells were cultured for one passage in BEGM with zinc added as a supplement to the ZD 
medium. Nuclear and cytoplasmic protein extracts were separated on 10% 
polyacrylamide-SDS gels, transferred onto nitrocellulose membranes, and incubated with 
anti-p53 antibody. Nuclear samples were probed with antibodies against Histone H1 for 
normalization. Autoradiography was visualized using enhanced chemiluminescence and 
quantitated by densitometry. Values are expressed as a percentage of ZN controls. 
Representative samples, from each treatment group, are shown below the bar graph. 
Values are means ± SEM from 3 separated experiments. Different letters indicate 
significantly different means, p < 0.05.  Similar results were obtained from experiments 




















































Fig. 4.6. p53 transactivation inhibitor Pifithrin treatment alleviated the blockage in 
G2/M. 
Cell Cycle analysis after the usage of p53 transactivation inhibitor Pifithrin. Pifithrin 
were administrated into the medium in 5 μM for 48 hrs. Cell cycle analysis of NHBE 
cells was assayed by flow cytometry using a FACScalibur cytometer. Cells were fixed in 
ethanol and stained with propidium iodide for DNA content. Flow cytometric data files 
were collected and analyzed using the CELLQuestPro program. Cell cycle distribution 
percentages of stained nuclei were calculated using Modfit LT software. Histograms are 
representative of three independent experiments. Similar results were obtained from 









































Fig.4.7. Upregulated Gadd45 protein was normalized by p53 transactivation 
inhibitor Pifithrin treatment. A). Gadd45 protein level after cells were treated in graded 
amount of Pifithrin. B). Relative nuclear Gadd45 protein levels in NHBE cells. Pifithrin 
were administrated into the medium in 2 μM for 48 h. Nuclear protein extracts were 
separated on 10% polyacrylamide-SDS gels, transferred onto nitrocellulose membranes, 
and incubated with anti-Gadd45 antibody. Nuclear samples were probed with antibodies 
against Histone H1 for normalization. Values are expressed as a percentage of ZN 
controls. Representative samples, from each treatment group, are shown below the bar 
graph. Values are means ± SEM from 3 separated experiments. Different letters indicate 
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s normalized by the p53 
ective zinc concentration (ZD <0.4 µM; ZN 
= 4 µM; ZA = 16 µM; and ZS = 32 µM zinc supplemented to the basal medium) for 4 
days. Pifithrin were administrated into the medium in 2 μM for 48 h. Meanwhile, cells 
were transiently transfected in serum free NHBE media by using Tfx-20 with 500 ng of 
luciferase reporter construct (pGL3-Gadd45) containing the Gadd45 promoter, together 
with 10 ng pRL-SV40 as internal control. pGL3 basal vector without carrying any 
promoter was used as the vector control. After transfection, the cells were cultured in 
corresponding media for 2 more days. Cells extracts were then assayed by 
Dual-Luciferase reporter system and signals were measured by a Luminometer. Values 
represent means ± SEM from 3 experiments. Data were analyzed by one-way ANOVA. 
Different letters indicate significantly different means (P < 0.05); while means with the 











Fig. 4.8. Enhanced Gadd45 promoter activity in ZS cells wa
transactivation inhibitor Pifithrin. 




































ig. 4.9. Re s 
ormalized by the p53 transactivation inhibitor Pifithrin. 











F duction of the CDK1 and Cyclin B1 complex level in ZS NHBE cells wa
n
N  media with respective zinc concentration (ZD <0.4 µM; ZN 
= 4 µM; ZA = 16 µM; and ZS = 32 µM zinc supplemented to the basal medium) for 4 
days. Pifithrin were administrated into the medium in 2 μM for 48 h. Five hundred of 
proteins from whole cell lysate were added to Protein G. The complex was then 
centrifuged and 10 μg of CDK1 antibody or rabbit polyclonal antibody were added to the 
precleared lysate. Protein A/G PLUS agarose was added and centrifuged. The 50 μl of 1X 
Laemmli sample buffer were added to the immunocomplexes as bead pellet. The 
immunocomplexes were vortexed, heated, and loaded onto the 10% SDS-PAGE gel for 









































































which m olgelstein 
et al. a he otein is tivated in a specific 
manner and this leads to either cell cycle arrest, or cellular apoptosis (Jin and Levine, 
2001). The process of cell division is highly ordered and regulated. Checkpoints exist to 
delay progression into the next cell cycle phase only when the previous step is fully 
completed (Hartwell et al., 1989). Checkpoints can become activated due to DNA 
damage, exogenous stress signals, defects during the replication of DNA, or failure of 
chromosomes to attach to the mitotic spindle. Abrogation of cell cycle checkpoints can 
result in death for a unicellular organism or uncontrolled proliferation and tumorigenesis 
in metazoans (Nyberg et al., 2002). Receptor proteins can detect DNA damage and 
initiate signal transducers, mediators, and effector proteins to phosphorylate targets that 
include p53, which that eventually results in cell cycle arrest at the G1/S, intra-S, or 
G2/M checkpoint until the lesion undergoes repair.  
G2/M progression is triggered by the maturation-promoting factor MPF, which is a 
complex of CDK1/Cyclin B1. p53 has been established to regulate G2/M checkpoint by 
transactivation of its target genes, including Gadd45. Gadd45 has been shown to interact 
with PCNA (Smith et al., 1994; Kearsey et al., 1995). Gadd45 also interacts with CDK1 
and inhibits its kinase activity by causing reduction of the Cyclin B1/CDK1 complex 
formation (Zhan et al., 1999). In addition, the induction of Gadd45, which resulted in the 
G2 arrest is associated with translocation of cytoplasmic Cyclin B1 (Jin et al., 2002). 
The p53 pathway is composed of a network of genes and their products that are 
eted to respond to stress signals that impact upon cellular homeostatic m
onitor DNA replication, chromosome segregation and cell division (V
, 2000). In response to a stress  acl, t  p53 prsign
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Moreover,
2/M arrest. Furtherm of G2/M arrest by Gadd45 requires p53 and 
depends on different type of DNA damage. Human cells with downregulated Gadd45 
expression or lymphocytes from Gadd45 knock-out m  failed to arrest at G2/M 
following UV or radiomimetic MMS, but demonstrated G2/M arrest after ionizing 
radiation (Wang et al., 1999).  
 
inc supplementation inhibits normal human bronchial cells proliferation 
Our studies were designed to investigate the influence of zinc depletion and 
pplementation on the cell signaling and cell cycle regulation in normal human 
eviously established to be 
 studies also reported that treatment 
ith high level of zinc not only inhibited cancer cell proliferation but also induced G2/M 
rrest (Jaiswal et al., 2004; Liang et al., 1999). Yet, an epidemiological study has reported 
 the overexpression of Cyclin B1 and CDC25 abrogated the Gadd45-induced 




bronchial epithelial cells (NHBE). Our findings demonstrated for the first time that the 
cell growth was inhibited at optimal zinc concentration pr
attainable in the plasma by oral supplementation. In zinc supplemented NHBE cells, 
cellular zinc was threefold higher than that of ZN control group (Fig.4.2), and cell growth 
as measured by cell number was decreased to 60% of ZN (Fig.4.1). Our study is the first 
to demonstrate that zinc supplementation, within the physiological range, is cytotoxic and 
reduces the growth of NHBE in primary culture. Thus, the high physiologic level of zinc 
also imposes adverse effect in normal cells. Controversy towards the efficacy of zinc 
supplementation in the prevention of cancer growth has been reported. Several studies 
have indicated that high cellular zinc levels inhibit cancer cell growth (Bataineh et al., 




an increase in risk for cancer development with usage of high level of zinc supplement 
(Leit
ownstream p53 regulator, Gadd45, 
bind
zmann et al., 2003). Even though zinc supplementation can inhibit cancer cell 
proliferation, the cytotoxic effect of supraphysiologic zinc levels (90 and 900 μM) 
resulting in the induction of DNA fragmentation has been observed in human primary 
liver cells (Paramannantham et al., 1996).  
 
G2/M blockage was found in ZS NHBE cells 
In our studies, cell cycle analysis by flow cytometry showed there was G2/M 
blockage in ZS cells (Fig. 4.3). In ZS cells, G2/M blockage was accompanied by three to 
fourfold induction of nuclear and cytoplasmic p53 proteins levels, respectively (Fig 4.5A 
& 4.5B), and by twofold increase in mRNA expression (Fig.4.4) as compared to ZN 
control cells.  These results suggest that zinc supplementation may induce cellular stress, 
resulted in the elevation of p53 expression. With the increase in p53 expression in ZS 
cells, G2/M blockage occurs to delay the transition and hinder cell growth. The 
underlying mechanism by which p53 blocks the G2/M cell cycle progression needs to be 
further investigated. This probably is due to the d
ing to CDK1, which decreases CDK1 kinase activity, and hinders the cell 
progression from G2 to M (Zhan et al., 1999).  High dosage of zinc in supraphysiologic 
levels has been reported to induce DNA fragmentation in human cells, implying that 
DNA damage may occur in high zinc supplementation. The induction of G2/M arrest 
mediated by Gadd45 in p53-dependent and independent pathways, which depressed 
CDK1 kinase activity and altered subcellular Cyclin B1 levels, have been observed in 
many cell types when exposed to stresses (Wang et al., 1999; Mullan et al., 2001; Maeda 
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et al., 2002; Jiang et al., 2003; Mak et al., 2004).  The effect of Gadd45 on the G2/M 
transition may be due to its ability to reduce complex formation of Cyclin B1and CDK1 
as well as inhibit the activity of CDK1/Cyclin B1 in vitro (Zhan et al., 1999; Jin et al., 
2000).  In the present study, no G1 arrest was observed. This is consistent with data 
from another study which showed that microinjected Gadd45 did not efficiently inhibit 
CDKk2/Cyclin E nor caused G1 arrest (Zhan et al., 1999).  
in ZS
 
Upregulation of p53 is associated with cell growth suppression and G2/M blockage 
 NHBE cells 
Our results demonstrate that cell growth suppression was accompanied by marked 
induction of p53 expression, suggesting that p53 may be the main regulator in cell growth 
inhibition in zinc supplemented NHBE cells. To determine whether p53 is the single 
regulator of p53-dependent pathway in response to cellular stress, we administrated p53 
inhibitor Pifithrin to suppress p53 transactivation activity. Our cell cycle analysis findings 
demonstrated that the G2/M blockage was alleviated by Pifithrin and normalized to 
similar levels as in all zinc treated cells (ZD-PFT, ZN-PFT, and ZS-PFT in Fig. 4.6), 
which suggested G2/M blockage is dependent on enhanced p53 expression in ZS NHBE 
cells.  
 
Upregulation of Gadd45 is p53-dependent in ZS NHBE cells 
To test whether Gadd45 expression was dependent on p53 pathway, we quantified 
the Gadd45 protein and assayed for the promoter activity after the p53 inhibitor Pifithrin 
treatment. Our result demonstrated that the Gadd45 expression and promoter activity 
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were dependent on the p53 pathway (Fig. 4.7 & 4.8). This finding is consistent with the 
results obtained from p53 null cells which failed to arrest at G2/M. Our finding suggested 
that the upregulation of Gadd45 is dependent on p53 at the transcriptional and 
translational levels.  
 
Enhanced p53 reduced CDK1/Cyclin B1 complex formation in ZS NHBE cells 
 of cyclins that bind and activate 
cycli
Cell division relies on the expression
n-dependent kinases to promote cell cycle progression to initiate mitosis. 
Association of Cyclin B with the Cyclin-dependent kinase CDK1 induces CDK1 kinase 
activity to promote progression through mitosis (Morgan, 1995). However, during a 
G2/M cell cycle checkpoint, Cyclin B is dissociated from CDK1, and these CDK1/Cyclin 
B1 complexes are thus reduced in the cells, which delay the progression through mitosis 
(Poon et al, 1996). To test whether p53 reduces the level of CDK1/Cyclin B1 complex, 
which formation and leads to G2/M delay in ZS NHBE cells, we examined the level of 
the CDK1/Cyclin B1 complex by immunoprecipitation. The amount of CDK1 and Cyclin 
B1 complex was decreased in ZS NHBE cells with the treatment of p53 inhibitor Pifithrin 
(Fig. 4.9). Thus, our results suggest that the upregulation of p53, induced by zinc 
supplementation, enhanced the reduction the level of the CDK1/ Cyclin B1 complex and 
delayed the G2/M transition.   
In summary, the present results presented above not only provide novel findings that 
zinc supplementation, in a physiologically relevant system, exerted adverse effect in 
normal cells, markedly elevated Gadd45 and p53 expressions and depressed 
CDK1/Cyclin B1 complex formation and inhibited G2/M progression were also observed 
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in NHBE cells. A better understanding of the mechanisms involved in the protection of 
normal cells from zinc cytotoxicity is essential for the identification of potential targets, 
and may contribute to the development of future therapeutic approaches for the treatment 









p53, reduces CDK1/Cyclin B1 complex formation and delays 
G2/M checkp
Enhanced activation of p38 MAPK upregulates Gadd45 and 
oint in zinc supplemented bronchial epithelial 
cells 
 
 regulation of G2/M cell cycle progression in response to 
the s
5.1. ABSTRACT 
Supraphysiologic level of zinc can induce cytotoxic stress, DNA fragmentation and 
cell cycle arrest. Even an elevated zinc status within physiologic range, created by 
culturing cells at optimal zinc concentration attainable in the plasma by oral zinc 
supplementation, can induce a delay in G2/M cell cycle progression for Normal Human 
Bronchial Epithelial (NHBE) cells. The present study was designed to examine for the 
first time the involvement of p38 MAPK in G2/M delay in zinc supplemented (ZS) 
NHBE cells in primary culture, by the usage of p38 dominant negative (pcDNA-p38DN) 
and p38 protein inhibitor SB202190. In the zinc supplemented NHBE cells, we provide 
evidence to show that an activation of p38 MAPK upregulated Gadd45 expression, 
increased the cytoplasmic but decreased the nucleus CDC25B levels, reduced the 
CDK1/Cyclin B1 complex formation, enhanced the activation of phosphorylation of p53 
at serine 15, and delayed G2/M cell cycle progression  These findings demonstrate the 
importance of p38 MAPK in the
tress induced by high zinc via cell cycle checkpoint regulatory proteins, including 




Human exposures to high zinc stress may cause significant health risk (Merchant et 
al., 2001). In addition, zinc toxicity can cause acute respiratory tract inflammation 
together with bronchial hyper-responsiveness. Moreover, studies have shown that 
workers in mining industries had increased polymorpho-nuclear leukocytes and incidence 
f pulmonary inflammation (Blanc et al., 1991). Furthermore, DNA fragmentation has 
een observed in Chang liver cells cultured in medium with supraphysiologic level of 
inc (Paramanantham et al., 1996). Here, we report that at the optimal physiologic 
oncentration of zinc, attainable in plasma level by oral zinc supplementation is cytotoxic 
to the normal human bronchial epithelial cells in primary culture by inducing G2/M 
checkpoint delay. The mechanism responsible for the delay in G2/M is not fully 
established. 
The p38 mitogen-activated protein kinase (MAPK) signaling pathway has a 
significant role in cell cycle regulation, apoptosis, cell development and cell 
differentiation (Ambrosino et al., 2001; Harper et al., 2001; Rincon et al., 2000), which 
are mediated by intracellular signaling pathway induced by external stimuli (UV, Ionizing 
Radiation), growth factors, and cytokines. In response to DNA damage, p38 MAPK is 
also involved in the regulation of growth-stimulation cell cycle regulators Cyclin D1, 
CDC25B and CDC25A (Bulavin et al., 2001).  
Growth Arrest and DNA Damage inducible gene 45 (Gadd45) has been implicated 
in cell cycle regulation, particularly in G2/M checkpoint, in response to DNA damage.  
Gadd45 proteins can bind the autoinhibitory domain of MEKK4 (MKKK), which is an 






activation of the MAPK cascade Under UV radiation stress, the 
induction of Gadd45 requires the activati
., 
19 ). 
53 has also been implicated in the control of the G2/M checkpoint. Introduction of 
53-deficient human fibroblasts results in G1/S and G2/M arrest 
(Aga
 
 (Mita et al., 2002). 
on of MAPKs (Tong et al., 2001).  
p38 MAPK has been established to contribute to the activation of p53 (Bulavin et al
99; Bulavin et al., 2002; She et al., 2000; She et al., 2001; Renchez-Prieto et al., 2000
p
wild-type p53 into p
rwal et al., 1995; Stewart et al., 1995). Evidence indicates that p53 and p21 are 
required for maintaining the G2 checkpoint in human HCT116 cells (Bunz et al., 1998). 
In addition, 14-3-3, which blocks Cdc25 activity and arrests cells at the G2/M transition, 
has been shown to be one of the p53 downstream genes (Hermeking et al., 1997). Gadd45 
is known to play an important role in the G2/M checkpoint in response to certain types of 
DNA damaging agents through p53-dependent or p53-independent pathway (Jin et al., 
2000; Wang et al., 1999; Zhan et al., 1999). 
The present study was designed to examine for the first time the involvement of the 
p38 mediating signaling pathway in the delay of G2/M progression in zinc supplemented 
normal human epithelial cells in primary culture. Herein, we provide evidence indicating 
that the activation of p38 MAPK upregulated Gadd45, enhanced the activation of p53 by 
phosphorylating p53 at serine 15, reduced the formation of the growth-stimulating cell 
cycle protein CDK1/Cyclin B1 complex, reduced the nuclear by increased the 
cytoplasmic phosphatase CDC25B, and delayed G2/M progression in zinc supplemented 
normal human bronchial cells.  
 99
5.3. MATERIALS AND METHODS 
Cell 
supplemented with growth components, and contained residual amounts of 
zinc 
  The ZA treatment was used as a 
repre
Culture and Treatment --NHBE cells were purchased from Cambrex Bio Science 
(Walkersville, MD). Cells were cultured in 100mm petri dishes containing bronchial 
epithelial cell growth medium (BEGM), supplemented with 0.5 µg/ml epinephrine, 10 
µg/ml transferrin, 5 µg/ml insulin, 0.1 ng/ml retinoic acid, 52 µg/ml bovine pituitary 
extract, 0.5 µg/ml hydrocortisone, 0.5 pg/ml human recombinant epidermal growth factor, 
and 6.5 ng/ml triiodothyronine without antibiotics, and cultured at 37°C in a 5% CO2 
incubator. The cells were grown to 80% confluence for 6 days, and subcultured using 
trypsin-EDTA. 
A zinc-free Bronchial Epithelial Basal Media (BEGM) baseline media, in which 
Cambrex omitted the addition of ZnSO4, was used as the zinc-depleted media.  This 
BEBM was 
(<0.4 μM), as detected by flame atomic absorption spectrophotometry.  The 
zinc-free basal medium of <0.4 μM was used as the zinc-depleted medium (ZD). For the 
other four treatment groups, zinc was added to the media in the form of ZnSO4.  For the 
zinc-normal medium (ZN) contained 4 μM of ZnSO4, the zinc-adequate medium (ZA) 
contained 16 μM of ZnSO4, and the zinc-supplemented medium (ZS) contained 32 μM 
ZnSO4.  The ZN medium was used as a comparison to standard culture media and was 
used as the control group for experiments.
sentative of human plasma zinc levels, and the ZS group was used to represent the 
highest plasma zinc level attainable by oral supplementation in humans. After NHBE 
cells were subcultured into one of the four corresponding groups, the cells were cultured 
overnight in ZN media before changing to their respective media. The p38 inhibitor 
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SB202190 was purchased from Sigma-Aldrich (St. Louise, MO). Chemicals were used as 
stock solutions in dimethylsulfoxide. SB202190 was administrated into the cells in the 
work
ined by using i) 
phos
 
CA). The human GAPDH probe was also included in the 
multi-p eping gene for normalization.  Labeled 
riboprobes were synthesized using the Non-Radioactive In Vitro Transcription kit with T7 
ing concentration of 10 μM for 48 h.  
 
Plasmid Transfection -- NHBE cells were transiently transfected with 2 μg of dominant 
negative plasmid construct that was p38 MAPK cloned into pcDNA3.1 vector, by using 
the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to manufacturer’s 
instruction. The dominant negative p38 plasmid construct was a kind gift from Dr. 
Jiahuai Han (Zhan et al., 1999). 
 
p38 Kinase Assay -- Kinase assay for p38 was performed with a p38 MAP kinase assay 
kit (cat# 9820, Cell Signaling, Danvers, CA) according to manufacturer’s protocol using 
recombinant ATF-2 as the substrate. Activation of p38 MAPK was determ
pho-specific antibodies and Western blot analysis and (ii) a p38 MAPK assay kit.  
 
RNase Protection Assay -- Total RNA was isolated from NHBE cells by using the 
RNAqueous Kit (Qiagen, Valencia, CA), according to manufacturer’s instruction. The 
integrity of the RNA was verified by electrophoresis and quantified by spectrophotometry. 
The mRNA abundance of human genes including, PARP, NF-κB, TNF-β, p53, Gadd45, 
p38, p21, Brca1, PCNA, MDM2, were measured by non-radioactive RNase Protection 
Assay (Pharmingen, San Diego, 
robe and was used as the house-ke
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RNA polymerase (Pharmingen), and Biotin-dUTP (Roche, Alameda, CA). 
hed in PBS (Ca2+, Mg2+ free), and fixed in 70% cold ethanol. Cells were 
store
LinearFlow Green and the DNA QC Particle kit, for verification of instrument 
performance, were purchased from Molecular Probes (Eugene, OR) and Becton 
Dickinson, respectively.  
 
Nuclear and Cytoplasmic Extract Preparation -- The NE-PER Nuclear and 
Cytoplasmic Extraction Reagents and the Halt Protease Inhibitor Cocktail Kits (Pierce 
Biotechnology, Rockford, IL) were used for nuclear and cytoplasmic extracts preparation 
RNase Protection Assay (RPA) was performed using the Pharmingen RPA kit. The 
PAGE gel resolved protected probes were transferred to nylon membrane and subjected 
to UV crosslinking. The biotin-labeled protected cDNA transferred to the membrane were 
detected by chemiluminescent signal and visualized by X-ray film exposure. 
 
Cell Cycle Analysis -- DNA contents of cells were assayed by fluorescence-activated cell 
sorting (FACS). NHBE cells were cultured in ZD, ZN, ZA, and ZS media for one passage, 
trypsinized, was
d at 4°C. For staining, cells were collected by centrifugation, and pellets were 
suspended in 1.0 ml propidium iodide staining solution (50 mg per ml propidium iodide, 
100 U per ml RNase in PBS), and incubated at room temperature for 1 h. Staining was 
quantitated with a FACSCalibur cytometer (Becton Dickinson, San Jose, CA). The cell 
numbers were acquired with CELLQuestPro software program (Becton Dickinson, San 
Jose, CA). Cell cycle distribution percentages of stained nuclei were calculated by using 
Modfit LT software (Verity Software House, Topsham, ME). The calibration standard 
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according to the manufacturer’s instructions, which are based on the method of Smirnova 
et al. (2000). Nuclear and cytoplasmic extracts were then stored in aliquots at -80°C. 
Protein concentrations were determined by using the BCA Protein Assay Reagent kit 
(Pierce, Rockford, FL). Contaminations of nuclear extracts by cytoplasmic proteins or 
uclear and cytoplasmic protein concentrations were 
etermined by using the Bicin Choninic Acid (BCA) kit (Pierce). Forty µg of protein 
 
CL, and 0.1% Tween 20) for 1 h at room temperature, prior to incubation with 1 µg/ml 
contamination of cytoplasmic extracts by nuclear proteins, detected by Western blot 
analysis of Hsp90 or Oct-1, respectively, were routinely found to be less than 5% in our 
lab.  
 
Western Blot Analysis -- N
d
were resolved on a 10% SDS-polyacrylamide gel electrophoresis and transferred to 
Hybond ECL nitrocellulose membrane (Amersham Pharmacia Biotech, Germany) by 
using a mini-transfer system (Bio-Rad, Hercules, CA).  Membranes were blocked with 
5% nonfat dry milk in PBS-T (10 mM phosphate buffer pH7.3, 137 mM NaCl, 2.7 mM
K
of primary antibody from Santa Cruz Biotechnology (Santa Cruz Biotechnology), in 
PBS-T containing 5% nonfat milk at 4°C overnight. Membrane was then washed three 
times with PBS-T and blotted with a secondary antibody conjugated with horseradish 
peroxidase (Santa Cruz, Santa Cruz, CA) at room temperature for 1 h, followed by three 
washes in PBS-T. The protein was visualized by using the SuperSignal West Pico 
Chemiluminescent Substrate (Pierce). Anti-Gadd45, anti-p53, anti-Cyclin B1, 
anti-CDC25B, anti-actin and anti-histone H1 were purchased from Santa Cruz 
Biotechnology. 
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Immunoprecipitation of CDK1/CyclinB1 – After reaching 70% confluency, cells were 
harv
entration in 
the whole cell lysates were determined by BCA reagent kit (Pierce).  Five hundred μg of 
tatistical Analysis --Each experiment was repeated at least three times. Data were 
ested and washed with 10 ml of PBS. Cells were then washed and resuspended in 1 
ml of cold lysis Buffer containing 1X Protease Inhibitor Cocktail (Pierce, Rockford, IL). 
Cells were then placed on ice for 30 min and centrifuged at 10,000 x g for 15 min at 4oC. 
The supernatant was collected in a new microcentrifuge tube.  Protein conc
proteins from whole cell lysate were added to 50 μl of Protein G (Santa Cruz 
Biotechnology), washed with cold lysis buffer, and incubated on ice for 1 h. The complex 
was then centrifuged at 10,000 x g for 10 min at 4°C. Ten μg of Cyclin B1 antibody or 
rabbit polyclonal antibody (Santa Cruz Biotechnology) were added to the precleared 
lysate and incubated for 1 h. Protein A/G PLUS agarose (Santa Cruz Biotechnology) was 
added and incubated at 4°C overnight on a rocking platform. The immunocomplexes 
were centrifuged at 10,000 x g for 30 seconds at 4°C and washed five times with 500 μl 
of lysis buffer. The 50 μl of 1X Laemmli sample buffer were added to the 
immunocomplexes as bead pellet. The immunocomplexes were vortexed and heated to 
95°C for 5 min and centrifuged at 10,000 x g for 5 min, and loaded onto the 10% 




expressed as means ± SEM. Statistical comparisons were carried out by one-way analysis 
of variance (ANOVA). Means were examined by the Least Significant Difference post 
hoc analysis (SPSS Inc., Chicago, IL). P < 0.05 was considered statistically significant.   
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5.4. RESULTS 
Zinc supplementation markedly reduced cell growth in normal human bronchial 
cells 
In ZD, ZA and ZS cells, cell growth as measured by DNA content per plate, was 
found to be reduced to 83%, 79%, and 67%, respectively, of the ZN cells (Fig.5.1A). The 
culture of cells in zinc depleted medium resulted in significant 18% reduction of cellular 
zinc as compared to control ZN cells (Fig.5.1B). Moreover, cellular zinc level in ZA and 
S cells was 150% and 300% of that of ZN control cells.  Thus cell growth was reduced 
p38 mRNA abundance was up-regulated in ZS NHBE cells 
p38 mRNA abundance was up-regulated in ZA and ZS NHBE cells to 195±31% and 
307±24%, respectively, of ZN control cells (100±21%) (Fig.5.1C). The mRNA 
abundance in ZD cells was 90±4% of ZN cells but the difference is not significant. Thus, 
 
respectively, to ZN (100±7%) control cells (Fig.5.2). These findings 
indicated the phosphorylation of p38 MAPK was upregulated in ZD, ZA and ZS, with the 
Z
both by the low-zinc and high-zinc status, particularly in ZS cells. Furthermore, a 
dose-dependent elevation in cellular zinc content was observed as the zinc concentration 
in the media was increased. 
 
in ZA and ZS cells, the marked elevations in p38 mRNA levels were associated with 
increases in cellular zinc levels and reduction in cell growth. 
p38 kinase activity was markedly elevated in ZS NHBE cells 
p38 kinase activities were increased in ZD, ZA and ZS cells to 177±10%, 238±24% 
and 256±14%, 
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highest increase in ZS cells. 
 
Suppression of p38 by Dominant Negative and protein inhibitor alleviated the delay 
in G2/M 
To determine that the increase in p38 expression and activation is associated with 
the delay in G2/M in ZS cells, we knocked down p38 kinase activity by dominant 
negative and protein inhibitor SB202190 in NHBE cells. Cell cycle progression was 
analyzed by flow cytometry after the suppression of p38.  After the application of p38 
dominant negative, the percentage of cells in G2/M was decreased from 8.81±0% to 
7.07±0.06% in ZD cells, from 9.40±0.17% to 8.67±0.05% in ZN cells, and from 
14.54±0.44 to 8.98±0.72% in ZS cells, respectively (Fig. 5.3A). Similarly, following the 
administration of p38 protein inhibitor SB202190, the percentage of cells in G2/M was 
decreased from 21.29±0.32% to 17.73±1.61% in ZD cells, from 20.47±0.28% to 
17.70±0.84% in ZN cells, and from 25.75±0.16% to 16.24±0.54% in ZS cells, 
respectively (Fig. 5.3B).  These findings demonstrated that the G2/M delay in ZS cells 
was dependent on the upregulation of p38 MAPK kinase activity. 
 
Upregulation of Gadd45 protein was normalized after suppression of p38 by 
ominant-negative and protein inhibitor d
To determine whether the enhanced Gadd45 protein was associated with the 
elevated p38 MAPK activity in ZS NHBE cells, we measured the nuclear protein level of 
Gadd45 after suppression of p38 with dominant negative and protein inhibitor 
(SB202190). The Gadd45 nuclear protein levels were knocked down to similar levels in 
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all p38 suppression groups treated with dominant-negative p38 (pcDNA-p38DN) 
nd 
DNA-p38DN (66±13%), as compared to ZN-control (100±1%) (Fig.5.4A). 
Simi
38 
To test whether the enhanced phosphorylation of p53 was dependent on the elevated 
lated p53 (serine 15) was 
quan
±
e enhanced phosphorylated 
p53 at serine 15 is dependent on p38 MAPK in ZS NHBE cells. 
Form
(Fig.5.4A & 5.4B), ZD-pcDNA-p38DN (70±12%), ZN-pcDNA-p38DN (40±2%) a
ZS-pc
larly, Gadd45 nuclear protein showed the similar trend in suppression of p38 by 
protein inhibitor SB202190, in ZD-SB202190 (54±17%), ZN-SB202190 (42±11%) and 
ZS-SB202190 (53±16%) cells, as compared to ZN-control cells (100±28%) (Fig.5.4B). 
These findings suggest that in ZS NHBE cells the upregulation of Gadd45 is dependent 
on the markedly elevated p38 MAPK expression. 
 
Enhanced phosphorylation of p53 at serine 15 was diminished after suppression of 
p38 by dominant-negative p
 
p38 expression in ZS NHBE cells, the amount of phosphory
tified after the administration of dominant-negative p38 among all treatments. The 
result showed that the enhanced phosphorylated p53 (serine 15) was diminished after 
suppression of p38 by dominant negative (Fig.5), in ZD-pcDNA-p38DN (22 4%), 
ZN-pcDNA-p38DN (38±5%) and ZS-pcDNA-p38DN (25±2%) cells, as compared to 
ZN-control cells (100±5%) cells. This result suggests that th
 
ation of CDK1 and Cyclin B1 in ZS NHBE cells was normalized after 
suppression of p38 by dominant negative and protein inhibitor 
In ZS NHBE cells, the formation of CDK1/Cyclin B1 complex was lower than ZN 
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control cells (Fig. 6A & 6B): ZS-control (53±7%) and ZS-pcDNA (58±3%) cells, as 
comp ±6%) cells (Fig.5.6A); ZS-control (52±5%) and 
 
the CDK1/Cyclin B1 complex showed no significant changes: ZD-control 
(118
the complex was dependent on p38 MAPK in ZS NHBE cells, the dominant-negative p38 
 compartments was affected 
after
ZD-pcDNA (175±29%), ZS-control (269±4%), ZS-pcDNA (234±16%), as compared to 
ared with ZN-control (100
ZS-Mock (64±6%) cells, as compared with ZN-control (100±17%) cells (Fig.5.6B). In
ZD cells, 
±9%) and ZD-pcDNA (103±9%) cells, as compared with ZN-control (100±6%) cells 
(Fig.5.6A); ZD-control (120±15%) and ZD-Mock (96±1%) cells, as compared with 
ZN-control (100±17%) cells (Fig.5.6B). To examine whether this reduced formation of 
and protein inhibitor SB202190 were administrated to suppress p38 MAPK.  In ZS cells, 
the reduction in CDK1/Cyclin B1 complex was normalized after suppression of p38 by 
dominant negative: ZD-pcDNA-p38DN (115±17%), ZN-pcDNA-p38DN (104±2%) and 
ZS-pcDNA-p38DN (108±9%), as compared to ZN-control (100±6%). Similarly, the 
reduced formation of CDK1/Cyclin B1 complex in ZS NHBE cells was normalized when 
p38 was suppressed by protein inhibitor SB202190: ZD-SB202190 (114±8%), 
ZN-SB202190 (104±1%) and ZS-SB202190 (105±5%) cells, as compared to ZN-control 
(100±17%) cells. 
 
Distribution of CDC25B in cytoplasmic and nuclear
 suppression of p38 by dominant-negative p38 and protein inhibitor 
The nuclear phosphatase CDC25B protein in ZA and ZS cells were reduced to 
49±4% and 30±5%, respectively, of ZN cells (100±13%) (Fig.5.7A). However, the 
cytoplasmic phosphatase CDC25B proteins were higher in ZD-control (118±9%), 
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ZN-control (100±12%) cells (Fig. 5.7B).  To test whether the distorted proportion of 
CDC25B between cytoplasm and nucleus was dependent on p38 MAPK, we used 
dominant-negative p38 and protein inhibitor to suppress p38. The results demonstrated 
that the higher amounts of CDC25B in the cytoplasm of ZD and ZS NHBE cells were 
normalized after the administration of dominant negative of p38. The amount of 
CDC25B in ZD-pcDNA-p38DN (58±26%), ZN-pcDNA-p38DN (62±26%) and 
ZS-pcDNA-p38DN (57±22%) cells, were not different from the ZN-control cells 
(100±12%) cells (Fig.5.7B). Similarly, the amount of CDC25B in the cytoplasm of ZD 
nd ZS cells treated with protein inhibitor SB202190 were decreased to similar levels: 
d 





ZD-SB202190 (62±9%), ZN-SB202190 (66±7%) and ZS-SB202190 (66±19%) cells, an






























d zinc-supplemented (ZS, 32.0 µM zinc) media for one passage. DNA 


































Fig. 5.1A. Zinc supplementation reduced cell growth in NHBE cells. 
DNA content per plate in normal human bronchial epithelial (NHBE) cells after cultured 
in zinc-deficient (ZD, <0.4 µM zinc), zinc-normal (ZN, 4.0 µM zinc), zinc-adequate (ZA, 




three experiments. Different letters indicate significantly different me
p < 0.05. Treatments with the same letters indicate no significant differen















































Fig. 5.1B. Cellular zinc level in NHBE cells. 
Cells after cultured in zinc-deficient (ZD, <0.4 µM zinc), zinc-normal (ZN, 4.0 µM zinc), 
nc-adequate (ZA, 16.0 µM zinc), and zinc-supplemented (ZS, 32.0 µM zinc) media for 
ne passage. Cellular zinc level in NHBE cells treated with different concentrations of 
 and ZS) for one passage. Cellular zinc was measured by flame atomic 
absorption spectrophotometry. Values are means ± SEM from three experiments. Means 
ith different letter are significantly different (p < 0.05).  
zi
o









ig. 5.1C. p38 mRNA abundance was up-regulated in ZS NHBE cells. 
.05. Treatments 



























Cells were cultured in ZD (<0.4 µM zinc), ZN (4.0 µM zinc), ZA (16.0 µM zinc), and ZS 
(32.0 µM zinc) media. Cells were cultured for 1 passage in BEGM with zinc added as a 
supplement to the ZD medium. p38 MAPK mRNA level was measured by RNase 
Protection Assay (RPA). RNase protection products were separated on a polyacrylamide 
gel and quantitated by laser densitometry. GAPDH was used as an internal reference, and 
values are expressed as a percentage of ZN controls. Representative samples from each 
treatment group are shown below the bar-graph. Values are means ± SEM from three 










































































Fig. 5.2. p38 kinase activity was markedly elevated in ZS NHBE cells. 
ells were cultured in ZD (<0.4 µM zinc), ZN (4.0 µM zinc), ZA (16.0 µM zinc), and ZS 
2.0 µM zinc) media. Cells were cultured for 1 passage in BEGM with zinc added as a 
for p38 was performed with a p38 MAP 




supplement to the ZD medium. Kinase assay 
kinase assay kit (Cell Signaling Inc.) according to manufacturer’s protocol by using 
recombinant ATF-2 as substrate. Activation of p38 MAPK was determined by using i) 
phospho-specific antibodies and Western blot analysis and (ii) a p38 MAPK assay kit. 
Representative samples from each treatment group are shown below the bar-graph. Values 
are means ± SEM from three experiments. Different letters indicate significantly different 



































Fig. 5.3A. Cell Cycle analysis after suppression of p38by dominant negative and 
alleviated the delay in G2/M.  Cell Cycle analysis after suppression of p38 MAPK by 
dominant negative. Cells were transiently transfected with 2 μg of pcDNA-p38DN for 48 
hrs with Lipofectamine. Cell cycle analysis of NHBE cells was assayed by flow 
cytometry using a FACScalibur cytometer. Cells were fixed in ethanol and stained with 
propidium iodide for DNA content. Flow cytometric data files were collected and 
analyzed using the CELLQuest program. Cell cycle distribution percentages of stained 

































Fig. 5.3B. Cell Cycle analysis after suppression of p38 by inhibitor SB202190. 
SB202190 were administrated into the medium at 10 μM for 48 h. Cell cycle analysis of 
NHBE cells was assayed by flow cytometry using a FACScalibur cytometer. Cells were 
fixed in ethanol and stained with propidium iodide for DNA content. Flow cytometric 
data files were collected and analyzed using the CELLQuest program. Cell cycle 























































Fig. 5.4A. Enhanced Gadd45 protein expression was normalized after suppression of 
p38 by dominant-negative. Gadd45 protein level after suppression of p38 by dominant 
negative. Relative nuclear Gadd45 protein levels in NHBE cells. Nuclear protein extracts 
were separated on 10% polyacrylamide-SDS gels, transferred onto nitrocellulose 
membranes, and incubated with anti-Gadd45 antibody. Nuclear samples were probed with 
antibodies against Histone H1 for normalization. Autoradiography was visualized by 
using enhanced chemiluminescence and quantitated by densitometry. Values are 
expressed as a percentage of ZN controls. Representative samples, from each treatment 
group, are shown below the bar graph. Values are means ± SEM from 3 separated 













































































































































Fig.5.4B. Enhanced Gadd45 protein expression was normalized after suppression of 
38 by SB202190. Gadd45 protein level after suppression of p38 by inhibitor SB202190. 
 
 are 
shown below the bar graph. Values are means ± SEM from 3 separated experiments. 
Different letters indicate significantly different means, p < 0.05.  
p
Relative nuclear Gadd45 protein levels in NHBE cells. Nuclear protein extracts were
separated on 10% polyacrylamide-SDS gels, transferred onto nitrocellulose membranes, 
and incubated with anti-Gadd45 antibody. Nuclear samples were probed with antibodies 
against Histone H1 for normalization. Autoradiography was visualized by using enhanced 
chemiluminescence and quantitated by densitometry. Values are expressed as a 










































































































Fig. 5.5. Accumulation of phosphorylated p53 was diminished after suppression of 
p38 by dominant-negative p38 
Total lysate extracts were separated on 10% polyacrylamide-SDS gels, transferred onto 
nitrocellulose membranes, and incubated with anti-phospho-p53 (ser15) antibody. 
Autoradiography was visualized by using enhanced chemiluminescence and quantitated 
by densitometry. Values are expressed as a percentage of ZN controls. Representative 
samples, from each treatment group, are shown below the bar graph. Values are 
means ± SEM from 3 separated experiments. Different letters indicate significantly 











































































Fig. 5.6A. Reduction of CDK1/Cyclin B1 complex formation in ZS NHBE cells was 
normalized after suppression of p38 by dominant negative. 
CDK1/Cyclin B1 complex formation after suppression of p38 by dominant negative. Five 
hundreds μg of proteins from whole cell lysate were added to Protein G. The complex 
then centrifuged and 10 μg of CDK1 antibody or rabbit polyclonal antibody was added to 
the precleared lysate. Protein A/G PLUS agarose was added and centrifuged. The 50 μl of 
1X Laemmli sample buffer was added to the immunocomplexes as bead pellet. The 
immunocomplexes were vortexed, heated and loaded onto the 10% SDS-PAGE gel for 
















































































































Fig. 5.6B. Reduction of CDK1/Cyclin B1 complex formation in ZS NHBE cells was 
normalized after suppression of p38 by protein inhibitor. 
lotting analysis using Cyclin B1 antibody.
CDK1/Cyclin B1 complex formation after suppression of p38 MAPK by inhibitor 
SB202190. Five hundreds μg of proteins from whole cell lysate were added to Protein G. 
The complex then centrifuged and 10 μg of CDK1 antibody or rabbit polyclonal antibody 
was added to the precleared lysate. Protein A/G PLUS agarose was added and centrifuged. 
The 50μl of 1X Laemmli sample buffer was added to the immunocomplexes as bead 
pellet. The immunocomplexes were vortexed, heated and loaded onto the 10% 
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ig. 5.7A. Enhanced shuttling of CDC25B from nucleus into cytoplasm was reduced 
y use of p38 dominant negative and protein inhibitor in ZS NHBE cells. Nuclear 
 
ranes, and incubated with 











CDC25B protein level. Nuclear and cytoplasmic protein extracts were separated on 10%
polyacrylamide-SDS gels, transferred onto nitrocellulose memb
anti-CDC25B antibody. Cytoplasmic and nuclear samples were probed with antibodies 
against Actin and Histone H1, respectively, for normalization. Autoradiography was 
visualized using enhanced chemiluminescence and quantitated by densitometry. Values 
are expressed as a percentage of ZN controls. Representative samples, from each 
treatment group, are shown below the bar graph. Values are means ± SEM from 3 
separated experiments. Different letters indicate significantly different means, p < 0.05.   





































ig. 5.7B. Enhanced shuttling of CDC25B from nucleus into cytoplasm was 
s. 
p38 by dominant negative. 
ated experiments. 







normalized by use of p38 dominant negative and protein inhibitor in ZS NHBE cell
Cytoplasmic CDC25B protein levels after suppression of 
Nuclear and cytoplasmic protein extracts were separated on 10% polyacrylamide-SDS 
gels, transferred onto nitrocellulose membranes, and incubated with anti-CDC25B 
antibody. Cytoplasmic and nuclear samples were probed with antibodies against Actin 
and Histone H1, respectively, for normalization. Autoradiography was visualized using 
enhanced chemiluminescence and quantitated by densitometry. Values are expressed as a 
percentage of ZN controls. Representative samples, from each treatment group, are 



















































































Fig. 5.7C. Enhanced shuttling of CDC25B from nucleus into cytoplasm was 
normalized by use of p38 dominant negative and protein inhibitor in ZS NHBE cells. 
Cytoplasmic CDC25B protein levels after suppression of p38 by protein inhibitor 
SB202190. Nuclear and cytoplasmic protein extracts were separated on 10% 
polyacrylamide-SDS gels, transferred onto nitrocellulose membranes, and incubated with 
anti-CDC25B antibody. Cytoplasmic and nuclear samples were probed with antibodies 
against Actin and Histone H1, respectively, for normalization. Autoradiography was 
visualized using enhanced chemiluminescence and quantitated by densitometry. Values 
are expressed as a percentage of ZN controls. Representative samples, from each 




38 MAPK mRNA abundance and kinase activity were enhanced in ZS NHBE cells 
 In this report, we present data for the first time that p38 mRNA abundance was 
induced in zinc supplemented NHBE cells 
ltured at optim  attainable in the 
lasma by oral supplementation. 
 
sphorylation in position serine 15  
The activation of p38 MAPK has been shown to arrest G2/M progression by 
osphorylation and stabil n mage induced by UV 
radiation in human fibroblasts (Bulavin et al, 1999; She et al, 2000). To test whether the 
 abundance and activated p38 MAPK activity may cause the 
s, the Gadd45 induced 
5
p
upregulated and the kinase activity was 
cu al zinc concentration, which has been shown to be
p
Activation of p38 MAPK induced p53 pho
ph izatio of p53 in response to DNA da
elevated p38 MAPK mRNA
accumulation of phosphorylated p53 (ser 15) in ZD and ZS NHBE cells, we examined 
the phosphorylated p53 levels in ZD, ZN, and ZS NHBE cells with or without the 
suppression of p38 MAPK by dominant negative (pcDNA-p38DN). This approach 
established that the accumulation of phosphorylated p53, in ZD and ZS NHBE cells, is 
dependent on p38 MAPK kinase activity because treatment of these cells with p38 
MAPK dominant negative resulted in a marked reduction in the phosphorylated p53 
protein levels (Fig. 5.5.). 
 
Activation of p38 MAPK induced Gadd45 protein expression 
The dependency of p38 in the role of Gadd45 protein in regulating cell cycle 
progression is a controversial topic. In medulloblastoma cell
apoptosis in response to nerve growth factor stimulation was found to be independent on 
e p38 kinase pathways (Chou et al., 2001).  In contrast, in UV-irradiated skin tumor, 
e inducti  kinase activity 
n fibroblasts induced 
either apoptosis nor p38 kin , in 
add45-deficient mice radiation-induced apoptosis or activation of p38 kinase pathway is 
 Gadd45 has been established to bind to MTK1 and 
activate MTK1 downstream activators including p38 (Takekawa et al., 1998). In our 
sults, we showed that the upregulation of Gadd45 protein is dependent on p38 MAPK 
 ZS NHBE cells. When the activated p38 MAPK was suppressed by dominant negative 
, the elevated Gadd45 protein was reduced markedly in ZD, ZN and ZS 
NHBE cells (Fig. 5.4A & 5.4B). These findings provided evidence to support the 
th
th on of of Gadd45 on apoptosis was dependent on p38
(Hildesheim et al., 2002). Overexpression of Gadd45 in huma
n ase activity (Sheika et al., 2000). Moreover
G




contention that the upregulated Gadd45 is dependent on p38 MAPK.  
 
Delay in G2/M checkpoint was dependent on p38 MAPK 
Cell division relies on the expression of cyclins that bind and activate 
cyclin-dependent kinases to promote cell cycle progression to initiate mitosis. 
Association of Cyclin B1 with the Cyclin-dependent kinase CDK1 induces CDK1 kinase 
activity to promote progression through mitosis (Morgan, 1995). However, during the 
G2/M cell cycle checkpoint, Cyclin B1 dissociates from CDK1 and results in a decrease 
in the Cyclin B/CDK1 complex in the cells, which delays the progression through mitosis 
(Poon et al, 1996). To examine whether the delay in G2/M in ZS NHBE cells is 
dependent on p38 MAPK, we investigated the influence of p38 MAPK on the G2/M 
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transition by suppressing p38 MAPK with dominant negative (pcDNA-p38DN) and 
 
/Cyclin B1 complex formation by immunoprecipitation. 
he amount of CDK1/Cyclin B1 complex was markedly reduced in ZS NHBE cells 
 to the 
redu
38 MAPK translocated phosphatase CDC25B from the nucleus to cytoplasm and 
inhibitor SB202190. In ZS cells, the delay in G2/M was alleviated after suppression of
p38 MAPK, and the amount cells in G2/M were relatively the same in all zinc treatment 
group (Fig. 5.3A & 5.3B), suggesting that the G2/M delay in ZS is dependent on p38 
MAPK.  After showing evidence of the dependency of G2/M delay in p38 MAPK in ZS 
cells, we then examined the CDK
T
(Fig.5.6), suggesting that the cellular stress induced by zinc supplementation lead
ction of the CDK1 and Cyclin B1 complex formation and the delay in G2/M 
transition.  To establish whether the decrease in the amount of CDK1/CyclinB1 complex 
is dependent on the activation of p38 MAPK, we determined the amount of the complex 
after suppression of p38 MAPK by dominant negative and inhibitor.  Our results 
demonstrated that the decreased of CDK1/Cyclin B1 complex in ZS cells was restored 
and normalized to the same level of ZN controls after the suppression of p38 MAPK 
(Fig.5.6A & 5.6B), suggesting that the decreased CDK1/Cyclin B1 complex is due to the 
increased p38 kinase activity. These results indicate that p38 MAPK reduced the 




caused the delay in G2/M in ZS NHBE cells 
The CDC25B phosphatase functions as essential regulators of cell cycle progression 
during normal eukaryotic cell division and as mediators of the checkpoint response in 
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cells with DNA damage (Strausfeld et al., 1991). CDC25B dephosphorylates 
phospho-Thr14 and phospho-Tyr15 on the CDK1/Cyclin B1 complex. 
Dephosphorylation of the CDK-cyclin complex leads to activation of these regulatory 
kinases, phosphorylation of their numerous cellular targets, and G2/M cell cycle 
progression (Morgan et al., 1997). The importance of CDC25B in cell cycle regulation is 
emphasized in the many studies that show the enhanced expression of CDC25B in a wide 
variety of cancers (Kristjansdottir et al., 2004). Regulation of the CDC25B phosphatase is 
therefore of critical importance in controlling cell proliferation. The activity of the 
CDC25 phosphatases is controlled by factors such as intracellular localization, 
phosphorylation by CDK1/Cyclin B1 complexes. Activation of p38 signaling pathway 
results in the activation of MAPKAP kinase-2 in response to stress from UV and 
cycloheximide (Bulavin et al., 2001; Lindqvist et al., 2004; Manke et al., 2005). 
MAPKAP kinase-2 binds to and phosphorylates CDC25B and this mediates the 
subsequent binding of 14-3-3 and the shuttling of CDC25B from nucleus into cytoplasm, 
 al., 2001; Lindqvist et al., 
2004
which together with 14-3-3 induce G2/M delay (Bulavin et
; Manke et al., 2005). A specific inhibitor of p38 has been shown to significantly 
reduce CDC25B/14-3-3 interactions and initiate the G2/M checkpoint response (Bulavin 
et al., 2001).  Our study demonstrated that the proportion of CDC25B in nucleus and 
cytoplasm was disrupted in ZS NHBE cells with lower amount of CDC25B protein in 
nucleus and higher amount of CDC25B protein in cytoplasm than in ZN control cells 
(Fig. 5.7).  This displacement of CDC25B from nucleus to cytoplasm may account for 
the G2/M arrest in ZS NHBE cells. Thereafter, we investigated the dependency of 
CDC25 shuttling on p38 MAPK activity by suppressing the activation of p38 MAPK by 
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dominant negative and inhibitor SB202190.  The present finding indicated that after 
suppression of p38 MAPK, the markedly elevated amount of cytoplasmic CDC25B in ZS 
cells was restored back to normal level as compared to ZN control cells, providing 
supportive evidence to show that the distorted shuttling of CDC25B was due to the 
activation of p38 MAPK which lead to and caused the delay in G2/M in ZS NHBE cells.  
Taken together, we report for the first time that the increase of p38 kinase activity 
and mRNA expression induced the delay in G2/M in ZS NHBE cells. In addition, the 
observed upregulation of Gadd45, accumulation of phosphorylated p53 at serine 15, 
reduction of the CDK1 and Cyclin B1 complex formation and shuttling of CDC25B to 
the cytoplasm are downstream events of the p38 MAPK signal pathway which results in 



























The project was designed to examine the effect of cellular zinc status on the signal 
transduction of tumor suppressor genes. Data generated support the induction of a signal 
transduction pathway involving Gadd45, p53 and p38 MAPK in the delay of G2/M 
progression in zinc supplemented (ZS) cells (Fig.6.1). This figure presents a possible 
overall signal pathway to summarize the cellular events constructed from the present 
findings. In ZS NHBE cells, the level of reactive oxygen species (ROS) was found to be 
approximately 20% higher than that of ZN control cells (Shih et al., 2007). The ROS 
generated by stress has been reported to induce the membrane receptors to trigger a series 
of cell signal reactions to protect cells from damage (Moiseeva et al., 2006). In our study, 
the ROS generated in high zinc stress may initiate the downstream cell signal 
transduction and induce the activation of protein kinases, such as MTK1, resulting in the 
activation of p38 MAPK. Environmental stresses, including UV radiation, ionizing 
radiation and osmotic stress have been shown to activate the p38 MAPK pathway 
(Takekawa et al., 1998). In the ZS cells, the enhanced activation of p38 MAPK 
upregulated Gadd45 expression, displaced CDC25B from nucleus to cytoplasm, reduced 
cellular levels of CDK1/Cyclin B1 complex, enhanced the activation of phosphorylation 
of p53 at serine 15, and delayed G2/M cell cycle progression, were returned back to 
similar level of ZN control cells by knocking down or suppressing p38 with dominant 
negative or protein inhibitor. Thus, these zinc supplementation induced cellular events 
appeared to be p38 MAPK dependent. 
SUMMARY 
Regulation of Gadd45 induction after DNA damage is complex and may be involved 
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in p53-dependent and –independent signaling pathways. Gadd45 induction by IR has 
been reported to be strictly dependent on normal cellular p53 function. p53 has been 
established to enhance Gadd45 expression and reduce the formation of CDK1/Cyclin B1 
complex and eventually arrest cells in G2/M progression in response to stress (Zhan et al., 
1999). Similarly, the zinc supplementation induced inhibition of cell growth, 
up-re
 ZS NHBE cells, implicating that the associated changes 
 this regulatory pathway are p53 dependent.  
Furthermore, the enhanced Gadd45 mRNA and protein expression, and enhanced 
hosphorylated p53 (ser15) and phosphorylated p38, blockage in G2/M cell cycle were 
artially normalized after the knock down of Gadd45 mediated by the RNA interference 
iRNA) approach, which demonstrated that the G2/M blockage is only partially 
ependent on Gadd45. Our results are consisted with previous finding that showed 
add45 was implicated in G2/M arrest in response to UV, IR or MMS stresses (Fornace 
t al., 1989; Zhan et al., 1999). Furthermore, our findings support the involvement of a 
ositive feedback loop consisting of Gadd45, p53 and p38 MAPK, in response to stress 
duced by zinc supplementation. Similarly, other studies have shown that upregulation 
f Gadd45 is capable of enhancing p53 protein level through a positive feedback loop by 
inding to MTK1 and activating p38 indirectly (Jin et al., 2003; Takekawa et al, 1998).  
gulation of p53 mRNA and protein expressions, and blockage of G2/M cell cycle 
progression were normalized by the administration of p53 protein inhibitor, Pifithrin, 
which inhibited p53 transactivation activity. After the inhibition of p53 transactivation 
activity, the enhanced Gadd45 promoter activity, upregulated protein expression, 
reduction in the cellular level of CDK1/Cyclin B1 complex, and delay in G2/M cell cycle 













Taken together, we reported uction in cell growth, delay in 
G2/M progression, decrease in the level of CDK1/Cyclin B1 complex, displacement of 
CDC25B from nucleus to cytoplasm, enhancement of Gadd45, p53, p38 MAPK mRNA 
and protein
for first time that a red
 expressions, as well as increases in phosphorylation of p53 and p38 MAPK, 
were Gadd45, p53 and p38 MAPK dependent in zinc supplemented NHBE cells. The 
cytotoxicity induced by high zinc stress may trigger the signal cascade composed of 
p38-p53-Gadd45-CDK1/Cyclin B1 and delay G2/M progression.   
A better understanding of the mechanisms involved in the protection of normal cells 
from zinc cytotoxicity is essential for the identification of potential targets, such as 
Gadd45, p53 and p38, and may contribute to the development of future therapeutic 
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